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1. INTRODUCTION 
1.1 General aspects 
Microorganisms, though hardly noticed in everyday life, form an integral part of our 
existence and are omnipresent. They adapt to constantly changing environmental 
conditions. As a matter of fact, in case of pathogens such adaptive behavior, may pose 
major problems for humans and other species. On the other hand for beneficial 
microorganisms that kind of adaptation is most desirable, offering many advantages. 
Amongst the most studied microorganisms belong the genera of Pseudomonas and 
Cupriavidus. Characteristic for some species of these genera is the production of 
compounds with antibiotic properties and others having biodegradation properties. For 
example the species Pseudomonas putida and Cupriavidus necator are able to carry out 
hydroxylation of organic substances and are therefore involved in the biological 
degradation of pollutants and xenobiotics. On the other hand, Pseudomonas 
aureofaciens is known to produce a wide spectrum of organic compounds with antibiotic 
properties. In order to maximize the benefits of these microorganisms, either a whole 
cell system, the enzyme complex or the particular enzyme that catalyses the reaction of 
interest is used. The use of natural catalysts such as whole cell systems and enzymes in 
order to perform chemical transformations of organic compounds is termed biocatalysis.  
Many reactions that are either difficult or nearly impossible to achieve with chemical 
methods are done with ease by biocatalyts (oxygenases/ hydroxylases), e.g. the stereo- 
and regioselectivity hydroxylation and oxygenation reactions.  
Oxygenases are widely distributed in animals, plants and micro-organisms and play a 
key role in very important biochemical pathways, being a target for drugs and are thus 
directly involved in drug metabolism[2]. It has been shown that most of oxygenases are 
specific and some of them even have unique biological functions. For example, 
indoleamine dioxygenase (IDO) is an immunomodulatory enzyme that is involved in 
immunological activities; prolyl monooxygenase serves as an oxygen sensor; nitric oxide 
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synthase converts L-arginine to nitric oxide (NOS); prostaglandin cyclo-oxygenase 
(COX) is involved in the biosynthesis of various prostaglandins, monoamine oxidase 
(MAO) catalyzes the oxidation of monoamines, cytochrome P-450 (CYP450) metabolizes 
various lipids[1-5].  
The great variety of enzymes that catalyze reactions with molecular oxygen as a 
substrate or cofactor are broadly classified into- oxidases, oxygenases, dioxygenases 
and monooxygenases (hydroxylases). Oxidases are membrane bound or soluble 
enzymes that catalyze the transfer of electrons to O2. Oxygenases catalyze the 
incorporation of O2 into the substrates and are subdivided in the classes of 
dioxygenases and monooxygenases. Dioxygenases catalyse the cleavage of molecular 
oxygen with subsequent incorporation of both oxygen atoms into organic substrates, 
while monooxygenases insert only one oxygen atom of O2 into the substrate[6]. 
 
1.2 Monooxygenases, a class of enzymes with great potential 
1.2.1 Monooxygenases 
Reactions catalyzed by oxygenase enzymes (mono- or dioxygenases) are interesting 
from a synthetic chemists perspective [8-10]. The advantages of the reaction catalyzed by 
oxygenases are:  high regio- and stereoselectivity and the absence of competing side 
reactions. Biological systems include numerous examples of mono- and dioxygenase 
reactions and a handful of chemical catalysts are known to compete with biocatalysts 
[11-13, 20]. Chemical procedures used to obtain the same end products often use toxic 
chemical oxidants, in contrast to biocatalysts like monooxygenases, which use 
molecular oxygen as an environmentally benign oxidant [14-18]. In the reaction catalyzed 
by monooxygenases, one oxygen atom of an oxygen molecule (O2) is transferred to the 
substrate while the second oxygen atom is reduced to water. 
Monooxygenases catalyze reactions such as heteroatom oxidation, Baeyer-Villiger 
oxidation, aromatic and aliphatic hydroxylation and epoxidation (Figure 1). Often, 
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these enzymes contain heme B or non-heme iron at the active site. The iron or the 
heme B binds and reduces molecular Oxygen to generate a reactive oxygen species 
intermediate which is required for the hydroxylation of the substrate[26,27].  Cytochrome 
P450 is a heme B containing monooxygenase. Another example is Fe(II)/α-
ketoglutarate (αKG) - dependent monooxygenase which catalyses a variety of reactions 
that result in biodegradation of pollutants, biosynthesis of antibiotics, repair of alkylated 
DNA/RNA and protein side-chain modifications[126].  
 
Figure 1: Examples of reactions catalyzed by 
monooxygenases. From left to the right: heteroatom oxidations, 
aromatic and aliphatic hydroxylations, epoxidations and Baeyer-
Villiger oxidations (figure adopted from [127]) 
 
 
 
In addition to cofactors like heme B and non-heme iron, some of the oxygenases are 
able to use oxido-reduction cofactors such as NAD(P)H or FADH2. To maintain the 
oxidation/reduction cycle in vivo, these redox cofactors must be recycled by various 
metabolic processes of a whole cell system. In the first step of a catalytic cycle, 
monooxygenases carry out the reduction of molecular oxygen, followed by the 
substrate oxidation and the release of hydrogen peroxide and other side products of the 
reaction generated from spent oxidation/reduction cofactors (Figure 2). 
  
Figure 2: Two step catalysis: FAD-dependent oxygenases 
use molecular oxygen to insert one oxygen atom into a substrate 
(S). NAD(P)H and FADH2 are the electron donors which 
subsequently reduce the second oxygen atom to water. 
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As shown in Figure 2, the overall reaction occurs in two steps. In the first step, FAD as 
substrate is reduced to FADH2, and then subsequently is used as a cofactor in the 
actual hydroxylation / oxygenation reaction. From this poit of view, there are 
monooxygenases able to perform both steps but others must be supplemented with 
FADH2 by a flavin reducing enzyme.  Given this fact, monooxygenases are divided into 
two classes: single-component flavin-diffusible and two-component flavin-diffusible 
monooxygenases (TC-FDM). The last is a class of yet understudied enzymes from the 
crystallography perspective, with just a few characterized crystal structures. Studies 
concerning the crystal structure of the monooxygenases would provide insights into 
their substrate specificity, making them more interesting for biotechnological processes. 
 
1.2.2 Activation mode 
The oxygenating agent that activates flavin-dependent monooxygenases is the C-4-α 
(hydro)peroxyflavin intermediate[52-56]. This instable intermediate is the product of a 
general oxido-reduction cycle in which NAD(P)H reduces the flavin and the reduced 
flavin reacts with O2 (Figure 3, steps I-II). As mentioned above, oxygenases are able 
to transfer the atomic oxygen on the substrate by two pathways: independent of any 
other enzyme or in complex with a flavin reductase[28,29] e.g. two-component 
flavin-diffusible monooxygenase (TC-FDM). In order to fulfill this complex catalytic 
process, several requirements must be accomplished by a single site of the enzyme. In 
the first pathway, the enzymes undergo significant conformational changes during the 
catalysis. These changes are associated with flavin dynamics[56] and are coordinated by 
the protein itself during catalysis[57-59]. 
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Figure 3: Mechanistic scheme of the FAD oxido-reduction single component flavin diffusible mono- 
oxygenases and two component flavin diffusible monooxygenases.  
 
Single-component flavoprotein monooxygenases have a unique catalytic cycle in which 
cofactors define the reaction velocity more than substrates (Figure 3)[65]. In the open 
conformation, monooxygenases move the isoalloxazine ring complex of FAD towards 
the solvent, exposing its N5 for hydride delivery from NAD(P)H (I)[56]. Molecular oxygen 
binds the reduced flavin and C-4-α peroxyflavin intermediate is formed (II). This 
species is stable for several hours because the monooxygenase is in the closed 
conformation. This conformation offers protection against the solvent which may 
destabilize it and C-4-α hydroperoxyflavin intermediate will complex the enzyme until 
substrate binding[64]. The enzyme complex will form a substrate access channel that 
allows passing of substrates. The ability of substrates to pass through this channel 
depends on their size and charge state[66,67]. When a substrate enters the active site 
through the substrate access channel, its nucleophilic moiety can react with the C-4-α 
hydroperoxyflavin intermediate (III). An oxygen atom is then incorporated into the 
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substrate and a water molecule is released (IV). In the last step, NADP leaves the 
active site closing the catalytic cycle [64-66]. Example for such a single-component 
monooxygenase is PhzS from P. aeruginosa[125].  
The second pathway uses two enzymes: a reductase that catalyzes the reduction of 
FAD to FADH- and an oxygenase that uses the reduced flavin (FADH-) as a substrate 
rather than a cofactor to react with oxygen and finally to hydroxylate the organic 
substrate[63]. This two-component flavin-diffusible monooxygenase system (TC-FDM) is 
able to transfer reduced flavin (FADH-) from the reductase component to the oxygenase 
and stabilize the C-4-α peroxyflavin intermediate until a substrate binds to be 
hydroxylated (Figure 3) [56,57,60-62]. This is an example that for successful reaction 
catalysis, protein complex dynamics play an important role. 
The first step (I) in Figure 3 depicts the binding of flavin reductase delivered FADH2 by 
the monooxygenase. This will behave as a substrate rather than a cofactor and will bind 
O2 in the second step (II), leading to the formation of the C-4-α hydroperoxyflavin 
intermediate. At this stage, the hydroperoxyflavin intermediate is acting as a cofactor 
shaping conformational changes in the tertiary structure of the monooxygenase which 
makes the real substrate bind. After product release, the third step (III) is finished, 
while the enzyme remains complexed by the C-4-α hydroxyflavin intermediate. This 
complex is very unstable and will spontaneously dissociate releasing FAD and water 
(IV)[57-59]. The oxidized form of FAD will enter a new redox cycle, first being reduced by 
the flavin reductase (Fre) and then delivered to the monooxygenase. 
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1.3 Biocatalysis 
For several decades already, scientists have understood the extraordinary potential of 
microorganisms and macromolecules for transforming and producing compounds in a 
“natural” way without using harmful chemical intermediates. New scientific fields were 
created in order to develop and/or modify enzymes given by the necessity to optimize 
biotechnological processes. In order to modify the conditions under which an enzyme is 
most effective in catalyzing a certain chemical reaction, the methods of protein 
engineering are used as most common methods. After a detailed biochemical and 
structural characterization of the enzyme, its effectiveness and its affinity towards 
substrates or compounds similar to the substrate can be increased by changing certain 
amino acids in its catalytically active site. The exchange of amino acids is brought about 
by creating mutations in the gene that encodes the enzyme. 
Biocatalysis can be defined as the acceleration of chemical reactions achieved by 
biological catalysts (enzymes). Enzymes consist entirely or predominantly out of one or 
more proteins and partly also a cofactor. Most of the biochemical reactions in living 
organisms are catalyzed by specific enzymes. From the onset of biocatalysis in industrial 
applications (biotechnology), enzymes, either isolated or in the living cell, are used to 
catalyze chemical reactions. Oxidation reactions are difficult to achieve using chemical 
approaches, making oxygenases interesting biocatalysts for biotechnological 
applications. Oxidation reactions in chemistry are followed in many cases by a high 
number of side products, low yield and mixed with racemic products. Enzyme catalyzed 
oxidation reactions are clean, efficient and able to provide stereo selective oxygenation 
products.  
Developments in the biotechnology have been extremely rapid in the last couple of 
decades, these being coupled to the progress achieved in the recombinant DNA 
technology but also because of the new applications of biocatalysts, which have been 
routinely applied in chemistry, leading to naturally obtained products.  
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1.4 Bacteria Pseudomonas and Cupriavidus 
1.4.1 Pseudomonas sp. 
Microorganisms are ubiquitous, but often unnoticed, because most of them are not 
pathogenic, or because they bring benefits to the organisms with which they live in 
symbiosis. A very much studied genus of microorganism is Pseudomonas. Because of 
their low life claims Pseudomonads are widespread, in soil and in water, wastewater 
and air. Many species of the genus Pseudomonas are characterized by the formation of 
colored or fluorescent pigment, so that they are easy to spot. Some species have 
thoroughly useful properties. P. putida, enters into a symbiosis with mycorrhizal fungi 
which promotes faster plant growth [33]. Another useful type is P. denitrificans, which 
denitrifies biological wastewater. However, there are also some harmful species in the 
genus Pseudomonas. P. aeruginosa is for example a human pathogen that is 
responsible for various infections such as wound and chronic lung infections in patients 
suffering on cystic fibrosis. Generally, the cause of the pathogenicity consists in the 
excretion of an arsenal of various virulence factors that also include phenazines. About 
phenazines and their biosynthesis many details are still unknown, so that they represent 
a great interest for scientific research. 
Pseudomonas aeruginosa is a yellowish, aerobic, gram-negative, motile, polar 
flagellated, rod bacterium isolated for the first time from clay near the river Maas[30]. 
 
Figure 4 Pseudomonas aeruginosa (figure adopted from [30]) 
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Other representatives of Pseudomonas include the strains P. aureofaciens 30-84, P. 
fluorescens 2-79 and P. chlororaphis PCL1391. Based on 16S rRNA analysis, P. 
aureofaciens has been placed in the group of P. chlororaphis. All these strains produce 
more or less the same small molecules but can differ in their biosynthetic properties 
with respect to phenazine derivatization. For example, P. aureofaciens possesses the 
monooxygenase PhzO, which was shown to convert the common phenazine precursor 
phenazine-1-carboxilic acid (PCA) into 2-hydroxy-phenazine-1-carboxilic acid (2OHPCA), 
a orange pigment (Figure 5). P. chlororaphis on the other hand expresses the 
transamidase PhzH, which converts PCA into phenazine-1-carboxamide (PCN), a green 
pigment[36, 37]. 
  
Figure 5 P. aureofaciens expressing 2-OHPCA, a orange pigment.[47] and P. chlororaphis 
expressing PCN, a green pigment[36-37] 
 
1.4.2 Cupriavidus necator  
Cupriavidus necator (formerly Ralstonia eutropha)[82] is a gram-negative soil ß-
proteobacterium that can be found in both soil and water. It was originally isolated 
based on its ability to use 2,4 dichlorophenoxyacetic acid (2,4-D) as a sole carbon 
source of energy. Cupriavidius necator is a non-pathogenic bacterium, facultatively 
aerobe, which means they can live in both aerobic and anaerobic environments. 
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Cupriavidius necator require non-halophilic environment and the optimal growth 
temperature is 30 ˚C [83]. 
 
Figure 6 Cupriavidus necator (formerly Ralstonia eutropha) (figure adopted from [86]) 
Cupriavidus sp. was shown to have a great potential for use in bioremediation, because 
of its ability to degrade chlorinated aromatic compounds which are often used as 
pesticides, but also for chemically related pollutants[84,85]. This bacterium became a 
model for studying microbial chemolithoautotrophic metabolism and for production of 
polyhydroxyalkanoates[86]. The latter ones are part of a divers spectrum of 
biodegradable polymers used as raw material for production of biodegradable plastics. 
This bacterial species is also capable of developing on hydrogen, thus contributing to 
the development of hydrogen-based biotechnological processes concerning various 
metabolites, polymers and other compounds [38-40]. 
 
1.5 Polychlorophenols 
1.5.1 PCPs 
Polychlorophenols (PCPs) are a commonly applied general biocide, used for many years 
as a bactericide, wood preservative, herbicide or precursor in the synthesis of 
herbicides, defoliant and detergent supplement in soaps [68-70]. PCP contamination of 
________________________________________________INTRODUCTION  
11 
soil, ground and see waters is common and its concentration tends to increase among 
many other hydrophobic xenobiotics, since they are highly hydrophobic, barely soluble 
in water and very resistant to biotic and abiotic attack[71-73]. An example of this kind of 
toxic compound is the 2,4,6 tri-chlorophenol (TCP), which can be found in soil and fresh 
water as a result of extensive usage of herbicides, fungicide, insecticide and other 
agrochemicals. 
 
1.5.2 TCP 
TCP is a chlorinated phenol, a yellow solid with a strong, sweet odor. It is carcinogenic, 
causing liver cancer, leukemia and/or lymphomas via oral exposure. 
 
 
Figure 7 Structure of 2,4,6, TCP 
 
 
A complete mineralization of these toxins requires the involvement of bacteria and 
bacterial consortia, which are gaining importance for toxicologists, biochemists, 
microbial genetics and microbial ecologists [75]. 
Polychlorophenols such as TCP are involved in the uncoupling of mitochondrial oxidative 
phosphorylation and in discharging the chemo-osmotic gradient generated by electron 
transport to drive the phosphorylation of ADP[74-76] .This is the main reason why PCPs 
are toxic to a variety of aerobic organisms, but there are some which are able to use 
PCPs as a carbon source, breaking them down chemically via biodegradation processes. 
In case of 2,4,6 trichlorophenol (TCP), this is dechlorinated stepwise to 2,6, 
dichloroquinone (2,6-DCHQ) and 6 chloroquinol (6-CHQ) respectively, as it is depicted 
in Figure 8.  
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Figure 8 Subsequential dechlorination of 2,4,6, trichlorophenol (TCP) to 6 chloroquinol (6-
CHQ) 
 
1.6 Biodegradation 
The definition of biodegradation has been given as a chemical breakdown of a certain 
compound by a physiological environment. This process became the major mechanism 
for the removal of spilled pollutant from aquatic environments, as well from the soil. To 
develop the process of biodegradation, a large volume of research on the biochemistry 
and genetics is involved turning this process into an important tool in the control of soil 
and water pollution. The physiological environment able to break certain toxins down 
chemically contains organism like bacteria, fungi or enzymes and protein complexes for 
in vitro biodegradation processes. In case of in vitro biodegradation, the reactions may 
be catalyzed by various groups of enzymes, for example oxygenases, dioxygenases, 
monoxygenases, methyltransferases or dehalogenases. An important role is played by 
cytochrome P-450 monoxygenases, which are present in microorganisms, plants and 
animals. These groups of enzymes are capable of dehalogenation, dealkylation, 
epoxydation, hydroxylation of xenobiotics[77]. The present work focuses in part on the 
biodegradation of chlorinated pollutants such as TCP. As for dehalogenation, this 
process involves a multi-step reaction. Biodegradation of polychlorophenols may occur 
in many different ways. One of them is the subsequent dechlorination by removal of the 
chlorine atoms or reductive dechlorination and insertion of hydroxyl groups to the 
aromatic ring[78]. Another way would be the transformation of polychlorophenols to a 
less toxic substrate without chlorine removal. The most common transformation in 
aerobic conditions is methylation or ethylation of the hydroxyl group in PCP compounds. 
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These reactions lead to the formation of chloroanisoles. They are less reactive and less 
toxic compounds than their substrates because of their higher hydrophobicity. 
Formation of anisoles was observed in Phanerochaete sp. cultures[79, 80], but also in 
higher organisms[81]. 
 
1.7 Phenazines, PCA and its derivatives 
1.7.1 Phenazines 
The concerted work of small molecules and macromolecules is the basis of the chemical 
machine that promotes life. Macromolecules like lipids, carbohydrates, nucleic acids and 
proteins are conventional biopolymers, essential in functions that are defined as life. 
Processes like storing and passing on genetic information, gene expression regulation, 
cell to cell communication, intercellular signaling and many other processes are strongly 
dependent on small molecules, also called metabolites. But not all of the small 
molecules play crucial roles in cellular functions. Some of them are not directly involved 
in the normal growth, development and reproduction of organisms and therefore they 
belong to the group of the so-called secondary metabolites. 
Many of the small molecules known before as secondary metabolites with unidentified 
roles gained importance in the survival of the living cell. Over the past couple of 
decades, secondary metabolites became an extensively researched domain since many 
of them are found to have interesting biological and chemical properties, such as 
antioxidant activities, antitumor, anti-inflammation and last but not least antibiotic 
activities. 
Phenazines form a well studied class of secondary metabolites,[34] and have been of 
great interest to pharmaceutical and clinical research groups for several years. 
Phenazines are nitrogen-containing aromatic compounds which have an antibiotic 
effect. Currently more than 100 naturally occurring phenazine derivatives are known, 
some of which are shown in Figure 9. The various compounds all have the same 
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skeletal structure and only differ in the substituents on the hetero-cycle, which affects 
the physical properties and biological activity. 
 
 
Figure 9:  
Some of the natural 
phenazine derivatives (figure 
adopted from [31]) 
 
 
 
Phenazines are synthesized almost exclusively by a variety of bacterial genera, including 
Pseudomonas, Burkholderia, Streptomyces, Pelagiobacteria, Brevibacterium, 
Burkholderia and Xanthomonas. Phenazines are generally water soluble and show 
distinctive coloration depending on the substitution groups (Figure 10)[49-50]. 
 
Figure 10: Some of the phenazine 
derivates produced by various 
Pseudomonas strains (figure adopted from 
[50]) 
 
 
Due to this coloration, phenazines are also used as pigments and in addition to this 
many of them exhibit broad spectrum antibiotic activity[48,49] and others are also 
involved in supplying the bacteria with iron. Through their strong redox activity, the 
phenazines are able to reduce insoluble Fe3+ occurring in the environment to the better 
soluble Fe2+, which then can be incorporated by the bacteria by the use of specific 
transport molecules. The antibiotic action is based on the redox activity of phenazines 
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where O2 is reduced to superoxide O2- and hydrogen peroxide H2O2. These two are very 
reactive oxygen species and have a toxic effect on sensitive cells. Examples of the 
defense of the habitat are the two phenazine derivatives 
2-hydroxy-phenazine-1-carboxylic acid (2OHPCA) and 2-hydroxy-phenazine (2OHPHZ), 
which have a very broad antibacterial and antifungal activity. These compounds are 
synthesized by P. aureofaciens, which colonizes the roots of plants and protect these 
against various plant pathogens. These phenazines are not dangerous for mammals, 
fish or insects, but this is not true for all of phenazine derivatives. In fact, some are of a 
great importance in bacterial infectious diseases. P. aeruginosa, which produces 
pyocyanin a blue phenazine pigment (Figure 10), causes chronic lung infection with 
about 90% of patients suffering from cystic fibroses. As was shown in a mouse model, 
the infection of P. aeruginosa can be better combated by the immune system when the 
synthesis of pyocyanin is limited or completely interrupted. Therefore, phenazines and 
the enzymes that synthesize them represent a particular interest to scientific research in 
the efforts to intervene effectively in reducing their harmful effects by controling the 
biosynthesis of these compounds [31, 32, 33]. On the other hand, the antibiotic properties 
of phenazine derivatives such as 2OHPCA and 2OHPHZ and the enzymes involved in 
their synthesis, constitute an interesting research target. The precursor of naturally 
occurring phenazine derivatives 2OHPCA and 2OHPHZ is the structurally simple 
phenazine-1-carboxylic acid (PCA). 
1.7.2 Phenazine biosynthesis 
The biosynthesis of phenazines is shown in Figure 11. According to the current 
understanding of phenazine biosyntheses, in most cases phenazine-1-carboxylic acid 
(PCA) is the common precursor of naturally occurring phenazine derivatives, but in 
some it may be phenazine-1,6-dicarboxylic acid instead. These basic structures are 
resulting from a synthesis catalyzed by several enzymes encoded in the conserved phz 
operon. First, chorismate is transformed by PhzE into 2-amino-2-desoxyisochorismat 
(ADIC). This is the substrate for PhzD, which will turn it into 
trans-2,3-dihydro-3-hydroxyanthranilate (DHHA); then PhzF will catalyse the 
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[1,5]-proton shifting to the ketone 6-amino-5-oxocyclohex-2-en-1-carboxylic acid, 
followed by isomerization. This ketone can dimerize spontaneously in vitro and a 
tricyclic phenazine precursor is formed. In vivo, the heterodimer PhzA/B will catalyze 
the double condensation[41]. The mechanism of the subsequent production of the 
precursors of PCA, which involves an oxidative decarboxylation and further oxidation is 
not yet clear [32, 41, 42]. 
 
Figure 11: The biosynthesis pathway of phenazine-1-carboxilic acid 
 
PCA can be further modified to strain-specific derivatives. P. aureofaciens, for example, 
has the phenazine-hydroxylating enzyme PhzO, which was investigated in this work. 
This enzyme converts PCA to 2OHPCA. The hydroxylated phenazine derivative 2OHPCA 
and its decarboxylated variant, the resulting 2OHPHZ, have stronger antibacterial and 
antifungal effects compared to the non-hydroxylated phenazine. A better understanding 
of the phenazine biosyntheses pathway responsible for the production of various 
phenazine derivatives can help to modify the relevant genes and enzymes so that new 
phenazine derivatives can be produced which show a significantly improved activity 
against pathogens and are at the same time safe for the fauna and flora. This could 
contribute to the development of new pharmaceutical products [33]. 
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1.8 The biocatalysts PhzO and TcpA 
1.8.1 PhzO 
The antibiotic activities of naturally derived phenazines have gained the interest in 
developing synthetic analogues for particular therapeutic applications, but synthesis of 
substituted phenazines turned to be difficult because of the lack of efficient methods[50]. 
PhzO from Pseudomonas aureofaciens is a monooxygenase that hydroxylates 
phenazines[33] and consists of 491 amino acids with a molecular weight of 55.1 kDa. 
PhzO catalyzes the reaction shown in Figure 12 where PCA is transformed to 2OHPCA, 
which can spontaneously decarboxylate forming 2OHPHZ. The oxygen atom transferred 
to PCA comes from the molecular oxygen O2, whose second oxygen atom is converted 
to water. For the oxygen transfer on the substrate, the cofactor FADH2 is essential as 
electron donor. FADH2 is consumed and transformed into its oxidized form FAD during 
the reaction [33]. Since FADH2 is a very unstable compound in aerobic conditions and 
cannot regenerate itself, it must be synthesized in situ by a flavin reductase (Fre), 
which requires NAD(P)H as a cofactor.  
 
Figure 12: The conversion of PCA to 2-OH-PCA catalysed by PhzO 
 
The gene coding for PhzO is located in phz operon, 271 nucleotides downstream of the 
phzG gene (Figure 13) and is preceded by a highly-conserved ribosome binding site 
GAGG [33]. 
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Figure 13: Position of the phzO in the phz operon (phzIRXYFABCG) in P. aureofaciens 30-84 
 
Homology comparison of the known amino acid sequence of PhzO shows that this 
enzyme has a similarity to bacterial aromatic hydroxylases and monooxygenases. PhzO 
belongs to the 4-hydroxyphenylacetate 3-hydroxylase (hpaB) family. The comparison 
points to the oxygenase component (hpaB) of the 4-hydroxyphenylacetate 3-
monooxygenase from Thermus thermophilus, which has an identity of 25.7% and a 
similarity of 43.7% to PhzO (EMBOSS protein alignment) and it was predicted to have 
nearly identical tertiary and quaternary structure. The phylogenetic relationships 
between PhzO and different bacterial aromatic monooxygenases are shown in Figure 
14.  
Since the hydroxylation activity of the enzymes including PhzO is dependent on the 
presence of a reductase component, these enzymes belong to the so-called TC-FDM 
family, the "two-component flavin-diffusible monooxygenase family"[43]. 
 
 
Figure 14: Phylogenetic 
relationships between different 
bacterial aromatic 
monooxygenases and PhzO. The 
Neighbor-Joining tree was 
created by using CLUSTAL W 
 
 
________________________________________________INTRODUCTION  
19 
It is assumed that PhzO may be responsible for the generation of a large variety of 
hydroxylated phenazine derivatives that is produced by P. aureofaciens[33]. The 
heterocyclic structure of PCA allows nucleophilic substitution reactions at some of its 
carbon atoms. Substitution with hydroxyl groups leads to the following PCA derivatives: 
2-hydroxy-phenazine-1-carboxylic acid (2OH-PCA); 6-hydroxy-phenazine-1-carboxilic 
acid (6OH-PCA); 2,3-dihydroxy-phenazine-1-carboxylic acid (2,3OH-PCA); 
2,6-dihydroxy-phenazine-1-carboxilic acid (2,6OH-PCA); 
2,4,6-trihydroxy-phenazine-1-carboxilic acid (2,4,6OH-PCA) and others. 
The chemical synthesizes of PCA derivatives is very difficult to achieve especially when 
taking the regioselectivity in account. There are several examples of how nature is 
handling these difficulties, for instance by using enzymes or enzyme complexes 
managing the stereo and regioselectivity properties of the catalyzed reaction. 
1.8.2 TcpA 
The tcpABC genes from Cupriavidus necator JMP134(pJP4) were shown to encode the 
enzymes that are involved in the degradation pathway of 2,4,6-trichlorophenol (2,4,6-
TCP) converting it into maleylacetate (MA) [87-90]. These genes are located adjacent to 
four other open reading frames: tcpY, tcpD, tcpR, and tcpX resembling them in a 
putative catabolic tcpRXABCYD operon (Figure 15) [89].  
 
Figure 15 The genetic organization of tcp genes in C.necator JMP134, tcpRXABCYD 
 
Partner flavin reductases are usually located in the same operon[92-95]. Indeed, the tcpX 
gene is 54% identical to another flavin reductase TftC from Burkholderia cepacia, which 
performes the same reductase process in the degradation of 2,4,5-TCP [91, 92].  
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The catabolic pathway for 2,4,6-TCP (Figure 16) was suggested to start with the 
conversion of 2,4,6-TCP to 2,6-dichloro-p-hydroquinone(2,6-DCHQ) followed then by its 
conversion into 6-chlorohydroxyquinol (6-CHQ-ol). Both reactions are catalyzed by flavin 
adenine dinucleotide (FAD)-dependent 2,4,6-TCP monooxygenase (TCP-MO). The next 
steps include the transformation of 6-CHQ-ol to 2-chloromaleylacetate (2-CMA) by 
6-chlorohydroxyquinol-1,2-dioxygenase (HQDO) and the conversion of 2-CMA to 
β-ketoadipate by NADH-dependent maleylacetate reductase (MAR) [87, 88, 96, 97]. 
 
Figure 16 Degradation pathway proposed for 2,4,6-TCP in C. necator JMP134. TCP-MO 
(monooxygenase), HQDO (hydroxyquinol 1,2-dioxygenase) and MAR (maleylacetate 
reductase) catalyze the conversion of 2,4,6-trichlorophenol (TCP) to 2,6-
dichlorohydroquinone, 6-chlorohydroxyquinol, 2-chloromaleylacetate, maleylacetate, and 
β-ketoadipate, respectively (figure adopted from [89]). 
 
The reaction catalyzed by TcpA is shown in Figure 17, where an oxygen atom will 
displace the chlorine from the para position followed by hydroxylation under reductive 
conditions. 
 
Figure 17 Reaction catalysed by TcpA. Molecular oxygen and reduced FAD are used to transform 
the substrate in 2,6 di-chloro-hydroquinone(2,6 Dcq), which under reductive conditions 
will convert into 6-chloro-hydroquinol (6 Chq-ol). 
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1.9 4-Hydroxyphenylacetate 3-Monooxygenase (HpaB) 
The structure of HpaB was used for modeling studies and comparison with the protein 
structures of PhzO and TcpA, as it will be shown in chapter 4.6. The 4-
hydroxyphenylacetate 3-monooxygenase is involved in the initial step of the 
degradation pathway of 4-hydroxyphenylacetate (4HPA). The enzyme catalyzes the 
hydroxylation of 4HPA to 3,4-dihydroxyphenylacetate (DHPA)[43].  HpaB is the 
oxygenase component of the 4-hydroxyphenylacetate 3-Monooxygenase from Thermus 
thermophilus HB8 and a member of the two-component flavin-diffusible 
monooxygenases. Kim et al[43] describe the crystal structure of the monooxygenase 
HpaB in three states: ligand-free form, in complex with FAD and in a ternary complex 
with FAD and the substrate 4HPA. In addition to the structural determination, the 
conformational changes that occur during ligand and substrate binding were also 
analyzed in detail. The crystal structures of all three states of HpaB are homotetramers, 
arranged as dimer of dimers. When FAD complexes the enzyme, conformational 
differences are observed at the loops between the sheets β5 and β6, and the loop 
between β8 and β9 (Figure 18 left marked in cyan). 
 
Figure 18 Left: stereo view of the structure of HpaB monomer with the N-terminal domain (yellow), 
the middle domain (cyan), the C-terminal domain (orange), and the α-helical tail (magenta). Right: 
Residues involved in forming the FAD binding pocket are highlighted in green. FAD and 4HPA are colored 
by element (C-green, N-blue, O-red, P-orange) 
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Figure 18 depicts the FAD-binding site which is shaped by residues marked in green: 
H142—R151, T183—T185, D247 and R433—R447. In addition, residues from the 
neighboring monomer, A312–V318 and Q378–S382 also contribute to the binding of the 
AMP moiety (data not shown). FAD is stabilized in the active site by the amino acids 
T183, L144, Q148, R151, H182 (Figure 19) and residues from the neighboring 
monomer S382, Q378, H317 and Y315. After FAD binding, the entrance of the groove is 
still wide enough to allow substrate and molecular oxygen to access the active site. The 
substrate 4HPA forms hydrogen bonds with the side chain of S197 and its main chain 
nitrogen atom and the side chains of the amino acids R100, Y104, H142 and T198 
(Figure 19). 
 
Figure 19 Left: 4HPA(cyan) is bound by the amino acids R100, Y104, H142, S197 and T198 
(green). Right: The cofactor FAD (cyan) is stabilized in the active site via hydrogen bonds with de 
residues L144, Q148, R151, H182, T183 (green) and S382, Q378, H317, Y315 from the neighboring chain 
(not shon here). Hydrogen bonds are marked with black dashes. 
 
These residues R100, Y104, and H142 are likely to select the substrate and define its 
orientation. All these residues are conserved in the E. coli type oxygenase components 
of the TC-FDMs family[43]. However amino acids involved in FAD binding are not 
conserved in enzymes that belong to the TC-FDM protein family.
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2. AIMS OF THIS WORK 
 
Oxygen-dependent enzymes are of great interest because they catalyze reactions that 
are difficult to achieve by chemical synthetic methods, characterized by high  
stereospecificity and regioselectivity. As aforementioned the large class of 
oxygen-dependent enzymes is classified into oxidases, dioxygenases and 
monooxygenases. The later contains the protein super family of two-component 
flavin-diffusible monooxygenases (TC-FDM). PhzO from Pseudomonas aureofaciens and 
TcpA from Cupriavidus necator are members of the TC-FDM protein family. While PhzO 
is involved in production of compounds with antibiotic properties, TcpA was shown to 
decompose xenobiotics and various environmental pollutants via dechlorination. 
The main aim of this work is to determine the structures of two two-component 
flavin-diffusible monooxygenases PhzO and TcpA, and to investigate their substrate 
specificity using X-ray crystallography and a variety of different biochemical and 
biophysical techniques.  
Biochemical studies on these enzymes could open up plethora of opportunities in 
biotechnology. A better understanding of the biocatalysis of hydroxylation and 
dechlorination processes could lead to better applications of polychlorophenol-
degrading organisms in the bioremediation of polychlorophenols. Based on the 
structure/activity relationships, new methods concerning site-specific hydroxylation 
could be developed. On the other hand, by changing the substrate specificity, PhzO and 
TcpA could become more interesting for biotechnology. 
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3. MATERIALS AND METHODS 
 
3.1 Materials 
3.1.1 Chemicals 
 
Chemicals Supplier 
Acetic acid Merck (Darmstadt, DE) 
Acetonitrile JT Baker (Deventer, NL) 
Acetone JT Baker (Deventer, NL) 
Acrylamid/ Bisacrylamid (30% w/v) Applichem (Darmstadt, DE) 
Adenosine diphosphate (ADP) Pharma Wadorf (Düsseldorf, DE) 
Adenosine triphosphate (ATP) Pharma Wadorf (Düsseldorf, DE) 
Ammonium carbonate Riedel de Haen (Seelze, DE) 
Ammonium sulfate Applichem (Darmstadt, DE) 
Ammonium persulfate (APS) Merck (Darmstadt, De) 
Ampicillin (Amp) Serva (Heidelberg, DE) 
Bradford reagent Bio-Rad (München, DE) 
Bromphenol blue Serva (Heidelberg, DE) 
Bovine serum albumin (BSA) Sigma 
Chloroform JT Baker (Deventer, NL) 
Chloramphenicol (Cam) Merck (Darmstadt, DE) 
Coomassie Brilliant Blue G250+R250 Serva (Heidelberg, DE) 
Dichlormethane JT Baker (Deventer, NL) 
Dimethylsulfoxide (DMSO) Fluka 
Disodium hydrogenphosphate JT Baker (Deventer, NL) 
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Dithioerythitol (DTE) Gerbu (Gaiberg, DE) 
Dithiothreitol (DTT) Gerbu (Gaiberg, DE) 
Ethylenediaminetetraacetic acid (EDTA) Gerbu (Gaiberg, DE) 
Ethanol JT Baker (Deventer, NL) 
Ethidium bromide Sigma 
Guanidinium hydrochloride (GdmHCl) Applichem (Darmstadt, DE) 
Glycerol Gerbu (Gaiberg, DE) 
Glycine Roth (Karlsruhe, DE) 
4-(2-Hydroxyethyl)piperazine-1-
ethanesulfonic acid (HEPES) 
Gerbu (Gaiberg, DE) 
Hydrochloric acid JT Baker (Deventer, NL) 
Imidazole JT Baker (Deventer, NL) 
Isopropyl-β-D-thiogalactopyranoside 
(IPTG) 
Gerbu (Gaiberg, DE) 
Kanamycin Boehringer (Mannheim, DE) 
Methanol Applichem (Darmstadt, DE) 
Β-Mercaptoethanol Serva (Heidelberg, DE) 
Phenylmethylsulfonylfluoride (PMSF) Sigma 
Potassium dihydrogenphosphate JT Baker (Deventer, NL) 
Potasium hydroxide JT Baker (Deventer, NL) 
2-Propanol JT Baker (Deventer, NL) 
Sodium chloride Fluka 
Sodium dihydrogenphosphate JT Baker (Deventer, NL) 
Sodium dodecylsulphate (SDS) Gerbu (Gaiberg, DE) 
Sodium hydroxide JT Baker (Deventer, NL) 
N,N,N´,N´-tetramethylethylendiamin 
(TEMED) 
Roth (Karlsruhe, DE) 
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Trifluoroacetic acid (TFA) Fluka 
Trihydroxymethylaminomethane (TRIS) Roth (Karlsruhe, DE) 
 
3.1.2 Other materials 
 
Amicon Ultra-4, 15 (30K) Concentrator Milipore (IE) 
BioSep-SEC-2000 gel filtration Phenomenex (Aschaffenburg, DE) 
Dialysis membrane tubing (MWCO:12-
14kDa) 
Spectrum Lab Inc. (Racho Dominguez, 
USA) 
Electroporation cuvettes Bio-Rad (München, DE) 
Eppendorf Tube (0.5 ml, 1.5 ml, 2.5 ml) Eppendorf (Hamburg, DE) 
Falcon Tube (50 ml, 15 ml) Falcon GmbH (Gräfeling-Locham, DE) 
HiTrap Ni-NTA column Pharmacia Biotech (Uppsala, SE) 
Jupiter 5µm C4 reverse phase column Phenomenex (Aschaffenburg, DE) 
Low molecular weight marker Amersham Biosciences (Uppsala, SE) 
NAP-5 desalting column Amersham Biosciences (Uppsala, SE) 
PD-10 desalting column Amersham Biosciences (Uppsala, SE) 
PRONTOSIL 120-5-C18-AQ 5 µm reverse 
phase column 
Bischoff-Chrom (Leor, DE) 
Superdex 75/200 Gel filtration column Pharmacia Biotech (Uppsala, SE) 
ZapCap filter Sigma-Aldrich (DE) 
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3.1.3 Instruments 
 
Äkta Prime system with REC112 recorder Pharmacia Biotech (Uppsala, SE) 
Biorad PE 9700 thermocycler Applied Biosystems (Weiterstadt, DE) 
Centrifuge Allegra X-22R Beckman Coulter (Palo Alto, CA, USA) 
Centrifuge Avanti J20-Xp Beckman Coulter (Palo Alto, CA, USA) 
Centrifuge Optima L-70K Ultracentrifuge Beckman Coulter (Palo Alto, CA, USA) 
Centrifuge Eppendorf 5415C/D benchtop Eppendorf (Hamburg, DE) 
Electroporation device E.coli Pulser Bio-Rad (München, DE) 
Deionized water apparatus Millipore (Eschborn, DE) 
Gel-electrophoresis system Bio-Rad (München, DE) 
High pressure liquid chromatography 
(HPLC) 
Waters (Eschborn, DE) 
HPLC-ESI-MS Agilent , Finnigan 
HPLC-APCI-MS Agilent , Finnigan 
Isothermal titration calorimeter MicroCal (Northampton, USA) 
Microfluidizer Microfluidics (Newton, USA) 
pH-Meter 761 Calimatic Knick (Berlin, DE) 
SDS-PAGE Mini-Protean II system Bio-Rad (München, DE) 
Shaker Infors (Bottmingen, CH) 
Thermomixer 5436 (1.5 ml) Eppendorf (Hamburg, DE) 
Ultrasonic cell disruptor (SONIFIER) Branson (Danbury, USA) 
UV/Visible Spectrometer DU 640 Beckman Coulter (Palo Alto, CA, USA) 
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3.1.4 Buffers and growth media 
 
LB medium LB agar plate 
5  g/l yeast extract 15 g/l Bacto agar 
10 g/l Tryptone 50 mg/l Ampicillin 
10 g/l NaCl   
    
Antibiotics SDS-PAGE running buffer (10x) 
125 mg/l Ampicillin 0.25 M Tris-HCl 
34   mg/l Chloramphenicol 2 M Glycine 
50   mg/l Kanamycin 1% (w/v) SDS 
    
SDS-PAGE stacking gel buffer (4x) SDS-PAGE resolving gel buffer (4x) 
0.5 M  Tris-HCl, pH 6.8 1.5 M Tris-HCl, pH 8.8 
0.4%(w/v)  0.4%(w/v) SDS 
    
SDS-PAGE loading buffer (2x) Coomassie staining solution 
62.3 mM Tris-HCl, pH 6.8 10% (v/v) Acetic acid 
2% (w/v) SDS 40% (v/v) Ethanol 
10% (v/v) Glycerol 0.1% (w/v) Coomassie brilliant blue 
R250 
5% (v/v) β – Mercaptoethanol   
0.001%(w/v) Bromophenol blue   
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Destaining solution TAE buffer 
10% (v/v) Acetic acid 40 mM Tris acetate, pH 8.5 
  2 mM EDTA 
  20 mM Glacial acetic acid 
    
PBS (10x) DNA loading buffer (5x) 
80 g/L NaCl 30% (w/v) Sucrose 
2 g/L KCl 20% (w/v) Glycerol 
14.4 g/L Na2HPO4 . 2H2O 0.2% (w/v) Orange G 
2.4 g/L KH2PO4   
    
Bug Buffer Buffer A for Ni-affinity 
chromatography 
50 mM Na2HPO4 ,pH 8.0 50 mM Na2HPO4 ,pH8.0 
0.3 M NaCl 0.3 M NaCl 
  2 mM β – Mercaptoethanol 
    
Buffer B for Ni-affinity 
chromatography 
Breaking/ lysis Buffer 
50 mM Na2HPO4 ,pH 8.0 25 mM Na2HPO4 ,pH 8.0 
0.3 M NaCl 0.5 M NaCl 
2 mM β – Mercaptoethanol 2 mM β – Mercaptoethanol 
0.5 M Imidazole   
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3.2 Molecular cloning methods 
3.2.1 General aspects 
The complete gene of phzO was extracted from P. aureofaciens genomic DNA by PCR 
amplification using a proofreading DNA polymerase (Phusion polymerase). The cloning 
into the expression vector pOpinE was performed by the Dortmund Protein Facility 
(DPF). The following oligonucleotide primers were used for polymerase chain reactions: 
5’-ATGCTAGATTTTCAAAACAAGCGTAAATATCTGAAAAGTG -3’ (PhzO-up strand) and 5’- 
TTTGGCGTTGAGCCCCACTAGGCG -3’ (complementary PhzO-low strand), whereby a 
1476 bp DNA fragment encoding PhzO was amplified using a PTC-200 thermocycler (MJ 
Research). The obtained PCR product was inserted into the pOpinE vector using the In-
Fusion™ cloning approach. DNA sequencing and analysis confirmed the accuracy of the 
resultant fusion product. 
 
3.2.2 Plasmids and bacterial strains 
3.2.2.1 Expression vector 
The expression vector used is from the plasmid depicted in Figure 20. The gene that 
encodes PhzO was cloned in the pOPINE-vector of Oxford Protein Production Facility 
using the In-Fusion PCR cloning system. This vector contains the gene for the enzyme 
β-lactamase, so that the bacteria that possess this plasmid have an ampicillin 
resistance. The phzO gene is preceded by a nucleotide sequence that encodes the His-
tag of six histidines. This way, the expressed PhzO will have an N-terminal His-6-tag 
which is important in the protein purification steps.  
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Figure 20: Physical map of the plasmid pOPINE-PhzO 
 
3.2.2.2 Bacterial strains 
Bacterial strains Genotypes 
  
XL1 Blue (Stratagene) recA1, endA1, gyrA96, thi-1, hsdR17, 
supE44, relA1, lac[F´,proAB, laclqZΔM15, 
Tn10(Tetr)]  
BL21(DE3) (Novagen) F- ,ompT, Ion, hsdS (rB- , mB-), dcm, gal, 
λ(DE3) 
BL21 (DE3) Codon Plus RIL 
(Stratagene) 
F- ,ompT, Ion, hsdS (rB- , mB-), dcm, gal, 
λ(DE3), endA, Hte [argU ileY leuW CamR] 
BL21(DE3) Rosetta (Novagen) F- ,ompT, Ion, hsdS (rB- , mB-), dcm, gal, 
λ(DE3), pRARE2 (CamR) 
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3.2.3 Polymerase chain reaction (PCR)  
DNA constructs used in this work were created with polymerase chain reaction. This 
reaction consists of a three-part cycle: denaturation in which a DNA template is 
denaturated at high temperature into single strands, followed by hybridization where 
the reaction is supplemented by the addition of complementary oligonucleotides and 
finishing with the elongation at moderate temperatures using DNA polymerase with free 
nucleotides to form double strands. In subsequent cycles, a new synthesized strand 
serves as a template. Remains of the reaction can be removed by PCR purification kits, 
but for a clean and pure product an agarose gel electrophoresis is required. 
 
3.2.4 Preparative PCR 
The reaction mixtures including the appropriate 5’- and 3’- primers were prepared as 
shown in table 3-1. 
Table 3-1 Protocol for preparation of PCR reaction mixture 
Step  Material Volume (µl) 
1 Sterile water 30-34 
2 Template DNA (10-100 ng) 2-6 
3 Buffer (Phusion High Fidelity 5x) 10 
4 DMSO 1 
5 Primers (final conc. 1 µM) 1 
6 dNTPs (10 mM, final conc. 100 µM) 1 
7 Enyzme: 3-5 units of Phusion Polymerase 1 
 Total 50 
The mixture was transferred into a PCR tube and incubated in the thermocycler using 
the PCR program described in table 3-2. 
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Table 3-2 PCR program 
Temp (C) Time Step description 
1. 98 1-2 min Initial denaturation: melting of DNA template and 
primers 
2. 98 30 s/cycle Denaturation: the first cycling event causes melting of 
DNA template and primers 
3. 50-68 30 s/cycle Annealing: the annealing temperature is dependent on 
melting temperature (Tm) of the primers, and usually is 2-
5C bellow Tm. 
4. 72 40 s/kb/cycle Extension: the time is dependent upon the length of 
amplifying fragment. 
5. 72 10-12 min Final elongation: after the last PCR cycle to ensure that 
any remaining single-stranded DNA is fully extended. 
6. 4 indefinite Final Hold: short-term storage of the reaction. 
Steps 2,3 and 4 are repeated 30-35 by times 
 
3.3 Subcloning 
3.3.1 Restriction 
For ligation of the DNA fragment with the vector, both components must be treated 
with the proper restriction enzymes to ensure a specific insertion. In this case the 
enzymes recognize individual palindrome DNA sequences and cleave double-stranded 
DNA at this specific point. The restriction digestion can be used for analysis of 
manufactured DNA or used in generating new plasmids. To perform a proper restriction 
digestion, the conditions are adjusted to those indicated by the manufacturer.(table3-
3) The mixture is incubated for at least one hour at 37 ˚C. 
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Table 3-3 Restriction enzyme digestion 
Step Material Volume (µl) 
Vector/Insert 
1 Sterile water 34 / 60 
2 Buffer (Fast digest 10X) 5 / 10 
3 Vector (0.2 µg/µl) or PCR          
product (0.1 µg/µl) 
5 / 20 
4 Enzyme: NdeI (20 U/µl) 3 / 5 
5 Enyzme: XhoI (20 U/µl) 3 / 5 
 Total 50 / 100 
 
3.3.2 Ligation of DNA fragments into a vector 
After the production and digestion of a PCR fragment, this was ligated with the desired 
vector to a plasmid. Both components had been previously digested with the same 
restriction enzymes, allowing in this way the T4 ligase to connect the protruding 3' and 
5' ends of the PCR fragments with those of the vector. The ligation mixture was made 
according to the protocol described in table 3-4 and incubated at 20 ˚C for 2-3 hours. 
Table 3-4 Preparation of ligation reaction mixture 
Step Material Volume (µl) 
1 Vector (10 ng/µl) 5 
2 Insert (15 ng/µl) 5 
3 Ligation buffer Rapid Ligase (5x) 4 
4 T4 rapid ligase (2U/µl) 2 
5 Sterile water 4 
 Total 20 
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3.3.3 Transformation 
For propagation of plasmids or for expression of proteins, the plasmids or ligation 
mixture must be transformed into certain bacterial E. coli strains. The transformation 
process is done with the electric shock method or the chemical-heat shock method. As 
follows bellow, the electric shock method will be described. 2 μl to 10 µl of ligation 
mixture or plasmid (up to 100 ng) were mixed with 70 µl E. coli competent cell 
suspension and incubated for 20 minutes on ice. After being transferred into an 
electroporation cuvett, the cells were exposed to a voltage of 2.4 volts for a couple of 
seconds. After the addition of 1 ml LB medium, the mixture was incubated at 37 ˚C for 
45 minutes. The cells were plated on LB plates with appropriate selection marker and 
incubated overnight at 37 ˚C. 
3.3.4 Colony PCR screen 
After overnight incubation at 37 ˚C, single growing colonies were picked randomly and 
analyzed whether they contain the desired DNA construct. The reaction mixture was 
prepared with respect to the protocol described in table 3-5. The mixture was then 
transferred into a PCR tube and incubated in the thermo cycler according to the PCR 
program described in table 3-2. 
Table 3-5 Protocol for colony PCR screening 
Step Material Volume (µl) 
1 Template DNA (single colony mixed with 
sterile water) 
5 
2 Buffer (RedTaq 10X) 1 
3 Primers A+B (final conc. 1µM) 1+1 
4 dNTPs (10mM, final conc. 200 µM) 1 
5 Enzyme: 1u Red Taq polymerase 1 
 Total 10 
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3.3.5 Isolation of plasmid DNA 
Plasmid DNA was purified in the required quantity from small to medium bacterial 
cultures per Miniprep kits from Qiagen. In this case the appropriate manufacturer's 
protocols were used. The isolation and purification are based on the principle of the 
alkaline lysis, subsequent precipitation of proteins with potassium dodecyl sulfate and 
separation by ion exchange chromatography. The DNA was finally eluted in H2O or TE 
buffer and stored at -20 ˚C. 
3.3.6 DNA sequencing 
The DNA sequencing was carried out with the chain termination method by cycle 
sequencing in the presence of fluorescently labeled dideoxynucleotides.[98] The different 
lengths of DNA fragments were separated by capillary gel electrophoresis combined 
with fluorescence detection. The DNA sequence can be read off from the resulting 
chromatogram since each dideoxynucleotide has a different fluorescent label. For the 
sequencing PCR, a Big-Dye Terminator mix was used, which consists of the AmpliTaq 
DNA polymerase and the four fluorescence-labeled ddNTPs (table 3-6).  
 
Table 3-6 Sequencing mixture 
Step Material Volume 
(µl) 
1 Plasmid (0.2-1 µg) 5 
2 Primers (3 pmol) 1 
3 BigDye mix 4 
 Total 10 
 
The protocol used for cycle sequencing is shown in table 3-7. 
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Table 3-7 The cycle sequencing program for DNA sequencing 
Temp ( C) Time Step 
94 2 min Initial 
denaturation 
94 20 s /cycle Denaturation 
50 30 s /cycle Annealing 
60 3 min /cycle Extension 
4 indefinite Hold 
PCR for 25-35 cycles  
 
After the incubation period in thermocycler, the mixture was precipitated with ethanol 
and the pellet dried after a washing step with 70% ethanol. The capillary gel 
electrophoresis and recording of the chromatogram was carried out in the 
biotechnological facility at the MPI-Dortmund. 
3.3.7 Glycerol stock 
For storage of transformed bacteria, the bacteria culture were grown to an OD600 = 0.4 
and then, 1 ml of bacterial culture is mixed with 1 ml 50% glycerol. After shock freezing 
in liquid nitrogen, the aliquots can be stored at -80 °C. 
 
 
 
 
 
 
_______________________________________MATERIALS AND METHODS  
38 
3.4 Protein Chemical Methods 
3.4.1 Protein expression strategies 
Using the homologous expression of a protein the yield of expression is mostly very low 
and the protein purification inefficient. In order to overcome these problems, the 
heterologous expression is used. Here, other easy- to- grow organisms, such as E. coli, 
are used to biosynthesize the protein in large amounts. The process of expressing 
proteins in large quantities is called over-expression. A special affinity tag, such as for 
example the His-6-tag which was used in this work, allows easier purification of the 
protein by affinity chromatography. The affinity tag can sometimes be eliminated by 
appropriate proteases after purification. The transcription of the target gene is 
controlled by the T7 RNA polymerase, which it comes from the T7 phage and was 
incorporated into the bacterial genome. The plasmid containing the gene for the desired 
protein has a T7 promoter and a T7 terminator recognition site. However, the 
transcription of the target gene is first induced when lac repressor is inhibited. The lac 
repressor binds to the operator, which is behind the T7 promoter, so that the T7 
polymerase cannot bind the promoter. By adding a suitable induction agent that binds 
to the lac repressor will lead to the dissociation of the lac repressor from the operator. 
The last becoming free, the T7 polymerase will bind to the promoter region and reading 
of the target gene will start. The T7 polymerase has such a high affinity to the promoter 
that gene expression is directed to the target gene. A commonly used induction agent is 
IPTG. This is not metabolized, so that its concentration remains constant and the 
repressor inactive.[99] Another way of induction is described by Studier auto-induction 
by lactose,[100] which was also applied here. Lactose can be converted by the enzyme β-
galactosidase into the isomer allolactose, which then binds to the lac repressor and thus 
induces gene expression. However, the induction takes place only when the glucose is 
consumed in the medium, as this would otherwise inhibit the absorption of lactose into 
the cells by the lactose permease. One advantage of the auto-induction with lactose in 
comparison with induction with IPTG is that cell cultures reach a higher optical density 
and therefore the protein yield achieved is much higher. Furthermore, the ratio of 
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glucose and lactose can be adjusted, which determines the time of induction such that 
the optical density of the culture has not to be monitored.[100-101] 
 
3.4.2 Expression of PhzO and TcpA 
3.4.2.1 Expression of native proteins 
The proteins PhzO and TcpA were expressed in Escherichia coli BL21-CodonPlus(DE3)-
RIL by inoculating Terrific Broth (TB) medium supplemented with 100 mg l-1 ampicillin 
and 34 mg l-1 chloramphenicol with an overnight culture that was grown from a single 
colony. The inoculated culture was grown at 310 K with continuous shaking at 250 rpm 
until OD600=0.4. Induction of gene expression via isopropyl β-D-thiogalactoside (IPTG) 
proved to be unsuccessful, and so another induction reagent was chosen. Inducing with 
0.2% α-Lactose for 22-24 h at 298 K the protein over expression was achieved. By the 
end of the expression the optical density of the culture showed OD600 = 1.2. The cells 
were harvested by centrifugation for 20 minutes at 4000 g and washed in 50 mM 
Na2HPO4 pH 7.5, 300 mM NaCl, 2 mM PMSF supplemented with a protease inhibitor 
cocktail.  
3.4.2.2 Expression of selenium-L-methionine labeled proteins 
The selenium-L-methionine labeled proteins were overexpressed in Escherichia coli 
BL21-CodonPlus(DE3)-RIL cells carrying pOpinE with His6-tagged PhzO or His6-tagged 
pET27-TcpA, respectively. The overnight culture was grown in Luria-Bertani medium 
supplemented by ampicillin and chloramphenicol, then harvested and resuspended in 
Minimal M9 medium. The culture was grown at 310 K until OD600=0.4, when amino 
acids lysine, threonine and phenylalanine to 100 mg l-1; valine, leucine and isoleucine to 
50 mg ml-1 and selenium-L-methionine to 60 mg l-1 were added. Protein expression was 
induced with 0.2% of α-Lactose for 30 hours at 298 K under rigorous shaking. 
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3.4.3 Cell disruption 
Depending on the amount of the harvested bacterial cells, these were disrupted either 
using a microfluidizer or by ultrasound. For this, the cells were resuspended in a lysis 
buffer which had an individual composition depending on the protein of interest. Using 
the microfluidizer the bacterial suspension was repeatedly placed in a narrow capillary 
under high pressure (800 bar) destroying the cell membranes. To check the complete 
lyses, the suspension was examined under the microscope. Subsequently, the lysate 
was centrifuged at 120,000 g for 45 minutes at 4 °C after which the insoluble 
components were separated from the aqueous fraction. 
To check the expression level and the protein solubility, samples were taken before and 
after induction, before lysis and after the centrifugation step from the supernatant as 
well from the inclusion bodies. Samples were loaded on a 15% SDS gel (see table3-8). 
 
Table 3-8 Recipes for preparing SDS-PAGE gels. 
 1 2 3 4 5 6 
Type of 
gel (%) 
Acrylamide/ 
bisacrylamide 
(29:1, 30%) 
Mili-Q 
H2O 
Resolving 
gel buffer 
(4X) 
Stacking 
gel 
buffer 
(4X) 
10% 
APS 
TEMED 
Resolving gel (60 ml) 
10% 20 ml 25 ml 15 ml - 300 µl 30 µl 
15% 30 ml 15 ml 15 ml - 300 µl 30 µl 
Stacking gel (30 ml) 
5% 5 ml 17.5 ml - 7.5 ml 240 µl 30 µl 
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3.4.4 Nickel Affinity Chromatography 
For purification of the proteins described in this work, the method of Nickel Affinity 
Chromatography was used. This method is based on the properties of a matrix formed 
by Ni-NTA (nickel-nitrilo-tri-acetic acid) and a well known property of the 
macromolecule of interest. The Ni2+ ions are complexing the NTA-material in such a 
way that two more ligand binding sites are freely accessible for positively charged 
molecules, such as histidines. The macromolecule of interest must have a special 
recognition sequence that will trap them on the solid phase Ni-NTA. A series of six 
histidines, called His-6-Tag, will specifically bind to these binding sites in the nanomolar 
range, while other proteins will not bind at all or just very weakly. During the washing 
steps, all the non-specifically bound protein can be washed away so that the matrix will 
contain the pure protein of interest. This is eluted by imidazole, which competes with 
the His-6-Tag for the free ligand binding sites on the nickel. 
After cell disruption, the cytosolic fraction was loaded on a nickel column and washed 
until absorption at 280 nm was no longer detected. In order to remove non-specifically 
bound proteins, the running buffer contained 20 mM imidazole. Subsequently, the 
desired protein was eluted with 100-250 mM imidazole and fractionated. The fractions 
were tested for purity using SDS gel electrophoresis and the correct mass was 
confirmed by ESI-MS measurements. Finally, fractions containing the desired and pure 
protein were combined. The imidazole was removed by dialysis or buffer exchange 
chromatography. 
 
Figure 21: Ni-NTA affinity 
chromatography. Binding of a protein 
with His-6-tag (figure adopted from 
[103]) 
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3.4.5 Preparative gel filtration 
Unlike the affinity chromatography, in the gel filtration proteins are not separated by 
binding to the matrix but because of their size and shape. The matrix consists of porous 
beads which have a defined size. These limit the permeation of large molecules in the 
beads and they have a shorter path through the matrix as the molecules that are 
smaller than the beads. The larger the molecule is, the faster it will be eluted.  
Size exclusion chromatography was used here for further purification of the protein of 
interest and for getting rid of pollutants originating from the affinity chromatography, 
but also for separation of aggregates from the rest of the protein. The separation was 
better, the smaller the volume of protein solution that was loaded on-to the column 
was. Depending on the size of the macromolecules, Superdex 75 16/60 or Superdex 
200 16/60 gel filtration columns (GE Healthcare) can be used. The flow rate here was 
not more than 2 ml / min. The collected fractions were analyzed by SDS gel 
electrophoresis and the desired fractions were then combined, concentrated, shock 
frozen in liquid nitrogen and stored at -80 °C. 
3.4.6 Analytical size exclusion chromatography 
In the analytical size exclusion chromatography, a method similar to the one described 
for the preparative gel filtration in 3.4.5, proteins are separated according to their 
stoichiometrical gradient. The difference between the analytical and preparative size 
exclusion chromatography lies in the smaller scale of the column, so that a considerably 
smaller volume of sample is needed. The column has a volume of 30 ml as compared to 
the preparative column that varies between 120 to 330 ml. For injection of samples, 
detection and sample analysis a computer-controlled HPLC system was used that was 
connected to a two-channel absorbance detector. To detect the mass of a protein, a 
gelfiltration standard (BioRad) is injected initially in the column and the elution volumes 
of the standard proteins are correlated with the elution volumes of the protein to be 
analyzed. Knowing the elution volumes for the standard proteins and for the protein of 
interest as well as the total and the exclusion volumes, the distribution coefficient  
for the column can be calculated as shown in the formula 3-1.  
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Formula 3-1 Calculation of the avK  -distribution coefficient, eV  : elution volume, 0V : 
exclusion volume, tV : total volume 
 
Plotting the avK  values versus the logarithm of the molecular mass of the standard 
proteins results in a linear relationship. From this relationship, the mass of an unknown 
globular protein can be calculated from its running/elution performance. 
In order to characterize the protein solution obtained in the two step purification of 
PhzO and TcpA regarding their purity, size and the number of subunits, the analytical 
gel filtration method described above was used. The first gel filtration run was 
performed with 20 µl of standard marker proteins (Bio-Rad) for determining the elution 
times of these proteins with known molecular weight. Then 10 µl of PhzO and TcpA 
solutions with a concentration of 200 µM were investigated and their elution profile was 
compared to the standard in order to determine their degree of polymerization in 
aqueous solution in vitro. The flow rate was 0.5 ml / min. 
 
3.4.7 Concentration of the proteins 
To increase the protein concentration, protein solutions were concentrated with Amicon 
ultra filtration units, whose membranes have pores with a defined size. By 
centrifugation at a maximum of 3500 g the protein solution is pressed by centrifugal 
force through the membrane. Molecules of smaller size than the pores of the membrane 
are passing easily, while larger molecules remain in the centrifuge cup. Decreasing the 
volume of the protein solution will increase the content concentration. The protein 
solution is centrifuged until the desired concentration is reached. 
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3.4.8 Determination of protein concentration 
Protein concentrations were determined by the method of Bradford[102] as well as UV-
absorption at 280 nm. 
The first method is based on the acid dye that binds Coomassie brilliant blue to the side 
chains of the amino acids arginine, histidine, tryptophan, tyrosine and phenylalanine, 
and thus the anionic form of the dye is stabilized. Compared to the unbound cationic 
form, the absorption maximum is shifted from 465 nm to 595 nm. In this study, the 
Bradford reagent used was produced by BioRad and the measurements of protein 
concentration were carried out according to the manufacturer. 
The second method for determining the protein concentration utilizes the properties of 
the aromatic amino acids to absorb at 280 nm. For a proper determination, this method 
requires a complete denaturation of the macromolecules with 6 M guanidinium. For 
calculating the concentration, any of the equations depicted in formula 3-2 and 3-3 
may be used. 
ε
MWA
C
*100*280
=  
Formula 3-2 UV-Abs. at 280 nm. C : concentration in g L-1, ε : extinction coefficient of the 
protein in mol-1cm-1, MW : molecular weight in g mol-1L-1.  
 
MW
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mg *120*1280*5690
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Formula 3-3 Nw, Ny, and Nc are the numbers of Trp, Tyr, and Cys residues in the protein 
with molecular weight MW and 5690, 1280 and 120 are the respective extinction 
coefficients for these residues. 
 
The extinction coefficient of the protein was determined by entering its sequence into 
the oline server ProtParam (https://us.expasy.org). 
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3.5 Biophysical methods 
3.5.1 Isothermal Titration Calorimetry (ITC) 
Isothermal titration calorimetry (ITC) is a very sensitive method to measure the 
thermodynamic parameters of interaction between two molecules [105]. In the binding 
process between two molecules, energy is released or consumed depending on the type 
of reaction. This heat energy can be recorded and measured. The measurement 
principle is in keeping the temperature between the measuring cell and the reference 
cell constant by an electrical control circuit. Depending on the type of reaction, less or 
more power is necessary to keep the temperature of the measuring cell the same as 
the temperature of the reference cell. The two cells are contained by an insulating coat 
to prevent the exchange of heat with the environment.  
In the calorimetric experiments of this study, the ligand was titrated stepwise with a 
syringe into the measuring cell that contained a protein solution of the binding partner. 
The heat exchange involved in keeping the temperature of the measuring cell equal to 
that of reference cell, when ligand and protein interact is detected and measured. The 
integral of the measured thermal effect is plotted versus the molar ratio of ligand 
(syringe) / protein (cell). A titration follows a sigmoidal curve from which the 
thermodynamic parameters for a binding, G∆ , H∆ , S∆ , the stoichiometry and the 
dissociation constant Kd can be determined. 
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Figure 22 (A) syringe (green) and cells (gray), (B) measuring unit, (C) representative ITC data 
(figure adopted from [107]) 
  
The free enthalpy  can be described by the Gibbs function: 
STHG ∆−∆=∆ *  
Formula 3-4 Gibbs function: G∆ : free enthalpy, H∆ : enthalpy, S∆ : entropy, T :Temperature 
 
The enthalpy H∆  and the entropy S∆  may have a different effect on the free enthalpy 
G∆ . The observed temperature change is caused by the non-covalent interactions 
between protein, ligand and solvent. Non-covalent interactions are formed by hydrogen 
bonds, hydrophobic interactions, ionic interactions, Van der Waals forces between 
ligand and protein, but also by structural changes in the solvation shell of the protein or 
ligand.[106] However, the factors which determine the size of  and  can vary. For 
example, by destroying the hydration shell of a protein around the binding pocket the 
entropy will increase. By complex formation, free particles are removed from the system 
and this will reduce the freedom for translational rotation. The amino acid side chains 
and / or entire domains are restricted in their mobility, which may result in a negative 
      A                                          B                                            C 
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entropy change.[107] The entropy measured while protein complex formation is also 
called solvation entropy or conformational entropy. 
The measurements were performed in a MicroCal VP-ITC apparatus, at 25 °C in 50mM 
Tris buffer (pH 7.5) and 150 mM NaCl. The apoenzyme placed in the sample cell was 
titrated consecutively with the following ligands: FAD, FMN, ADP, AMP, PCA, DCP and 
TCP. The syringe containing the ligand was set to stir with 180 rpm, at 25 ˚C in 50mM 
Tris buffer (pH 7.5). The ligand molecules were dissolved exactly in the same buffer as 
the protein. To perform the measurements, different concentrations of the enzyme, 
from 50 µM to 400 µM, were prepared and the ligand concentration was adjusted to the 
tenfold of the enzyme concentration. After 30 minutes of equilibration the measurement 
started with an initial 0.2 µl injection, followed by 18 injections of each 2 µl at 4-minute 
intervals. 
The raw data of the enthalpy changes corresponding to the measurements performed 
in this work, were analyzed and computed with Origin version 7 (OriginLab 
Corporation). The equation used for the plotting the curve is shown below in formula 
3-5. The association constant K for the binding of the ligand L and the protein P can be 
described as: 
L
K
*)1( υ
υ
−
=
 
Formula 3-5 K : association constant in M-1, υ : binding ratio (proportion of occupied ligand 
binding sites), [ L ] :concentration of free ligand in M 
The mass balance for the ligand  is: 
[ ] [ ] [ ]00 *** PnLL υ=  
Formula 3-6 [ L ]0: initial total concentration of ligand in M, [ L ]: free ligand concentration in 
M, [P]0 : total concentration of the protein in M, n :number of binding sites,  υ : 
binding ratio (number of the ligand-occupied binding sites ) 
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Combining equation 3-5 with equation 3-6 will give: 
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Formula 3-7  
The measured heat Q  for a certain bonding ration υ  is: 
[ ] 00 **** VHPnQ ∆= υ  
Formula 3-8 Q : heat  quantity in J, H∆  binding enthalpy in J mol-1, 0V  : volume of the 
measuring cell 
 
Inserting the calculated bond ratio  from formula 3-7 into formula 3-8, the measured 
heat  becomes: 
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Formula 3-9 Q  is the heat measured in J, [ ]0P : total concentration of the protein in M [ ]0L : 
total concentration of ligand in M, 0V : volume in the cell in l, H∆ : molar 
enthalpy of ligand binding in J mol-1, n  : number of binding sites of the protein, 
K : equilibrium association constant in M-1 
The stoichiometry of binding n , the association constant K  and the molar enthalpy H∆  
can be determined in a single experiment.  From the value of H∆  and S∆ , and the 
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relationship STHKRTG ∆−∆=−=∆ *ln  the Gibbs free 
energy G∆  and the entropy S∆  can be calculated. 
3.5.2 Mass Spectrometry 
3.5.2.1 ESI-MS 
The mass of micro and macromolecules can be determined by matrix-assisted laser 
desorption/ionization mass spectrometry (MALDI-MS) or electrospray ionization mass 
spectrometry (ESI-MS). The process for ESI-MS is sensitive and far gentler than MALDI-
MS but also more easily upset by salt contained in the protein solutions. The sample is 
therefore injected in a C4 desalting column before the analysis in the ionization 
chamber with a high electrical potential is started. The resulting dispersion is charged 
electrically, and proteins and micro molecules contained in the gaseous phase are 
getting protonated. In an ion trap the protonated micro and macromolecule fragments 
are analyzed and raw data are collected. The processing and evaluation of the raw data 
is made with the help of software MagTrans, which calculates the molecular mass of the 
molecules under consideration with high exactness. 
 
Figure 23 Electrospray ionization mass spectrometry ESI-MS (figure adopted from [117]) 
In this work, ESI-MS was used to verify successful labeling of the proteins with 
selenium-L-methionine during the protein overexpression, by measuring the molecular 
weight. The programs used for ESI-MS measurements are listed in table 3-9. 
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Table 3-9 Gradient program for LC-ESI-MS measurement of protein using a C4 column 
Time (min) Buffer A (0.1%FA, H2O)% Buffer B (0.1%FA, ACN)% 
5 20 80 
15 70 30 
17 90 10 
19 90 10 
20 20 80 
22 20 80 
 
3.5.2.2 HPLC - APCI - MS Measurements 
In the HPLC-APCI-MS analysis, the liquid chromatography process is coupled to mass 
spectrometry. First, the sample of interest is separated by HPLC into its individual 
components. These are evaporated and ionized during the ionization process (APCI) 
and then passed to the detector, which will analyze the components based on the 
mass / charge (m/z) ratio. 
In the HPLC process, components are separated based on their polarity. The stationary 
phase is formed by silanes with long, non-polar hydrocarbon chains. The interaction of 
the substances with the stationary phase is thus via hydrophobic interaction. Samples 
are usually located in a polar solvent and are eluted with non-polar organic solvents like 
acetonitrile, methanol or isopropanol. The organic solvent competes with the analyte for 
the binding sites of the stationary phase so that it is washed away from the column and 
detected by a UV detector.[103] 
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Figure 24 HPLC apparatus (solvent 1: H2O, solvent 2: ACN, 
MV: mixing valve, PV: sample valve) (figure adopted from [110]) 
The separation of the compounds via HPLC is followed by their mass determination with 
the method of atmosferic pressure chemical ionization mass spectroscopy (APCI-MS). 
For this, the analyte is directed into a nitrogen steam through a capillary, atomized into 
a spray and heated up to the temperature of 300 to 400 °C. Then, the ionization takes 
place by means of a needle-shaped electrode, called the corona needle to which a 
voltage of 4 to 5 kV is applied. By corona discharge, the solvent molecules will be 
ionized in the first step with consecutive protonation by the corona. These primary ions 
in turn ionize in a second step, the analyte molecules.[112] 
 
Figure 25 APCI apparatus (figure adopted from [109]) 
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After ionization, mass analysis of the ions takes place under high vacuum conditions 
using a quadrupole. Here, four rod-shaped metal electrodes are arranged in parallel, 
with adjacent electrodes which are polarized in the opposite manner. (Figure 26) By 
applying a combined AC/DC field, only ions having a defined mass / charge ratio will 
have a stable oscillation and reach the detector. The remaining ions collide due to their 
unstable trajectory with the metal electrodes and do not reach the detector. By 
changing the voltage of the field applied it can be achieved that each type of ion is 
detected individually in order to analyze the entire mass spectrum.[103] 
 
 
Figure 26 Quadrupol mass analyzer (figure adopted from [108]) 
The method described above was used to monitor the hydroxylation activity of PhzO. 
The reaction was carried out in the presence of FADH2 delivered from the NADH/FAD 
oxido-reduction reaction and catalyzed by the flavin reductase Fre from Escherichia coli. 
Substrate concentration decrease and product concentration increase were monitored. 
Separation of the substrate from the product was achieved with an Atlantis C18 column 
and the eluted compounds were then analyzed in real time by APCI-MS. Assays were 
performed under aerobic condition at 20 ˚C and under rigorous shaking in the 
thermomixer at 300 rpm in 20 mM Tris-HCl (pH 7.5) containing 1 mM FAD, 200 µM 
PCA, 1 µM Fre, 5 mM Na2S2O4 as reducing agent and 10 µM caffeine. To initiate the 
reaction 5 mM NADH and 20 µM PhzO were added to the reaction mixture. Immediately 
after the reaction started, a sample of 20 µl was taken and mixed with 20 µl of 
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acetonitrile supplemented by 0.1% acetic acid to quench the reaction. This sample was 
considered to be at 0 min after reaction initiation. Other samples were taken at 
different time intervals: 2, 5, 10, 15, and 20 minutes. Assays were repeated varying 
cofactor, substrate, and enzyme concentration. A cross check was performed by 
repeating the same assay in absence of PhzO. Caffeine was added to the reaction as an 
inert component to scale the results of various measurements, thus permitting the raw 
data computation. The results were processed by the Xcalibur software for the 
integration of the peaks and determination of the compounds based on mass charge 
ratio Microsoft Office and Origin7 were used to plot the results on graphs.  
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3.6 Protein crystallography 
3.6.1 Introduction 
For the biochemical study of enzymes with yet unclear or undefined activity it is very 
helpful to know their spatial structure. The structural characterization of proteins can 
predict to some extent or explain the reaction mechanism catalyzed by the enzyme and 
its substrate specificity. The most common methods used for determining protein 
structure are X-ray crystallography, NMR and electron microscopy. Images obtained 
with electron microscopy show the quaternary structure of a protein or enzyme 
complex, in contrast to X-ray crystallography, which delivers information at atomic level. 
In case of optical microscopes the maximum achievable resolution of a lens d  is 
proportional to the wavelength λ  of the light and inversely proportional to the 
refractive index n : 
n
d
*2
λ
=  
The refractive index for most materials is approximately 1 and a carbon-carbon single 
bond is about 1.5 Å. In order to obtain a resolution at atomic level, the wavelength 
employed must be at least 0.3 nm. The visible light (VIS) and ultra violet (UV) have 
wavelengths in the range of micrometer (µm) and nanometer (nm), respectively. X-rays 
coming e. g. from a Cu rotating anode have a wavelength of 0.154 nm, while the 
synchrotron light is about 0.01 nm.  
 
Figure 27 The electromagnetic spectrum (figure adopted from [116]) 
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3.6.2 Crystallization 
If one wants to study a protein structure by X-ray analysis, this must be first 
crystallized. A so-called “single crystal” contains many protein molecules arranged in a 
perfect and uniform crystal lattice so that radiation coming from any region of the 
protein molecule will add up to a strong signal. The crystal serves as a kind of amplifier 
for diffracted X-rays. The most commonly used method to crystallize proteins from a 
solution is vapor diffusion. This method requires very pure proteins and also a high 
concentration of about 10 mg/ml. In a crystallization plate, a drop of 0.1 µl to 2 µl of 
the protein solution is mixed with an equal volume of reservoir solution. The 500 µl of 
reservoir solution and the drop mixture are in a sealed cavity of the plate. The reservoir 
solution contains a water attracting precipitant as well as salt and a buffer maintaining 
the pH level. Precipitants like polyethylene glycol (PEG) will induce the movement of the 
water molecules from the drop containing the protein solution through the gaseous 
phase into the reservoir solution. In this way, the protein is concentrated slowly, until 
its solubility limit is exceeded and it eventually forms crystals. Temperature plays also 
an important role in the crystallization processes. By higher temperatures of up to 25 ˚C 
the vapor diffusion is faster, leading to rapid crystallization in case of very stabile 
proteins. Other options would be crystallization at 4 ˚C and 12 ˚C, which stabilizes the 
protein in the crystallization plates for longer time and lowers the chances for protein 
precipitation. 
If the protein and precipitant concentrations are further increased in the supersaturated 
region, this can lead to precipitation of the protein (Figure 28). The crystallization 
phase diagram is a function of the protein and precipitant concentration. Crystal growth 
is possible only in the supersaturated region. 
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Figure 28 A schematic drawing of a protein crystallization phase diagram based on the protein and 
precipitant concentrations (figure adopted from [117]) 
 
In order to determine the appropriate crystallization conditions for each protein, initial 
screening experiments are carried out in which a variety of conditions are tested. To 
this end, the sitting drop method was used in a 96 well format in the scale of 200 nl. 
The drops were pipetted here by a robot (Mosquito, TTPLabtech, UK). The conditions 
under which crystals were growing are then further optimized in order to obtain large 
and well-shaped crystals. The fine tuning of the initial conditions was performed 
manually with the hanging drop method in a 24 well format and in a 2 µl drop-scale. 
(Figure. 29) 
 
Figure 29 Crystallization by vapor diffusion method in hanging (left) and sitting drop (right) 
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3.6.3 Cryo-protection 
For minimizing the radiation damage in the crystals during data collection at higher 
temperatures, the method of cryo-protection at 100 K in nitrogen flow was used. The 
crystals were transferred from their crystallization solution into a cryo-solution and 
cooled in liquid nitrogen. The most commonly used cryo-solutions are characterized by 
low water content in order to prevent the formation of ice crystals, which scatter the X-
ray as well. In this work, the cryo-solutions were obtained by adding 15% glycerol or 
10% PEG400 to the crystallization conditions. 
 
3.6.4 Data collection and processing 
After suitable preparation of the crystals with cryo protectant (3.6.3), they were 
analyzed with monochromatic X-rays. In this work a Cu-Kα radiation at about 1.54 Å at 
100 K was used. Dataset collection was performed at beamline X10SA of the Swiss 
Light Source (SLS) at the Paul Scherrer Institut (Villigen, Switzerland) using a MAR 225 
detector. A diffraction pattern with regularly spaced reflections of different intensities is 
shown in Figure 30.  
 
Figure 30 Diffraction pattern of a protein crystal (TcpA) 
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The diffraction patterns of the scattered X-rays include almost the complete information 
excluding the phase, about the three-dimensional arrangement of the atoms in the 
crystal. The position of the atoms can be calculated by knowing the following 
parameters: wavelength and amplitude of the electromagnetic wave of the X-ray beam 
and by determining the phase of the wavelength with special methods. 
From the intensities of the reflections and the distances and angles between them, the 
cell parameters lengths and angles of the unit cell of the crystal lattice can be 
calculated using a computer program package such as XDS/XSCALE[119]. Based on the 
values of the reciprocal unit cell parameters, the Bravais lattice type of the unit cell are 
determined. During the indexing procedure, the correct crystallographic coordinates h, 
k, l (Miller indices) are assigned for each detected reflection. The quality of the data 
was evaluated by calculating the value of Rsym: 
[ ]
[ ]hkl
ihkl
hklhkli
ihkl
sym I
II
R
∑∑
∑∑ −
=
|| ,
 
Formula 3-10 Ii,hkl = observed intensity of the i-th related reflection with Miller indices hkl, [Ihkl] = 
average intensity of the reflections Ihkl 
 
The wavelength of the X-ray beam diffracted by the crystal is identical with the 
wavelength of the initial beam. To calculate the electron density map of the protein 
structure, the value of the structure factor )(hklF

must be determined. This is 
obtained from the structure factor amplitudes |F(hkl)| and of the phase angle α: 
)(2|)(|)( hkliehklFhklF απ=

 
Formula 3-11 hkl = position of the lattice point in reciprocal lattice, F(hkl) = structure factor of the hkl 
reflection, |F(hkl)| = structure factor amplitude, α(hkl) = phase information 
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The relative intensity of the beam can be determined by the degree of blackening of an 
X-ray film or digitally by measuring the intensity of a reference spot on the detector. 
The relative intensities I(hkl) are proportional to the square of the structure factor 
amplitudes |F(hkl)|: 
2|)(|)( hklFhklI ∞  
The electron density  at any point  in the Cartesian coordinate system can be 
derived from the structure factor amplitude and the phase angles calculated as follows: 
∑ ++−=
hkl
lzkyhxihkli eehklF
V
xyz )(2)(2|)(|1)( παπρ  
Formula 3-12 )(xyzρ  = density of the Cartesian coordinates x , y and z ; V  = the volume of the 
unit cell; F  = structure factor amplitude defined as a function of the crystallographic 
coordinates h, k and l. 
 
The Fourier transformation gives a preliminary structure model of the protein based on 
the diffraction data, but is still lacking information concerning the phase, which cannot 
be measured directly by experiment, but must be determined by special methods (see 
sections 3.6.5). 
 
3.6.5 Solving the phase problem 
As mentioned earlier, it is not possible to determine the phases directly from the 
resulting X-ray diffraction peaks. To solve the phase problem, four approaches are 
available: molecular replacement, singular or multiple anomalous dispersion (MAD), 
singular or multiple isomorphic replacement (SIR / MIR) and the direct method of phase 
determination for small molecules. 
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3.6.5.1 Molecular replacement (MR) 
The method of molecular replacement (MR) can be used when the crystal structure of a 
structurally similar protein is already known and can be used as a model. For this, 
databases like NCBI and PDB are browsed for proteins with high sequence identity to 
the protein of interest, as they often have a very similar structure. Through molecular 
replacement, the structure factor amplitudes and phases are calculated backwards from 
the coordinates of the model. Combining the phase of the model αcalc and the measured 
structure amplitudes |Fobs| of the crystal, an electron density map for the new crystal 
structure is generated. The space group and the orientation of the model can differ 
from the new crystal structures and therefore the model must first be optimally fitted in 
the new crystal cell. This is done via rotation functions by adjusting the three rotational 
and three translational variables using the Patterson map of the model and the 
observed structure factor amplitude |Fhkl|. The better they match, the better is the 
resulting rotational and translational function. After the model is applied to the crystal 
unit cell, the new electron density can be calculated based on its structure. 
 
3.6.5.2 Singular or multiple anomalous dispersion (SAD/MAD)  
Proteins labeled with heavy atoms are used in order to determine the phase of their 
structure. There are two principle methods of labeling with heavy atoms: incorporating 
selenium-L-methionine recombinantly instead of methionine or site specific and non-
covalent incorporation of heavy metals. In the last, heavy atoms are incorporated in the 
protein structure by soaking experiments, where the solution containing the crystals is 
supplemented by different concentrations of various heavy metals. These will diffuse in 
time into the crystals. 
The reflections (hkl) and (-hkl) are defined as Friedel pairs. In non-derivatized protein 
crystals, the structure amplitudes of the Friedel pairs are identical. For heavy metal 
atoms, this is no longer valid if they absorb X-rays of a certain wavelength and emit it 
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again as anomalous diffraction. The resulting differences in intensity are called 
anomalous dispersion, which becomes significant especially when the excitation of the 
metal is near the wavelength of the X-ray beam. From the intensity differences, one can 
determine the exact position of the heavy metals and also the phase of the heavy 
metals from which the phase of the whole protein can be assessed (Figure 31).  
 
 
Figure 31 Correlation of native and derivative scattering factors: |Fa| and |Fa’’| (anomalous 
scattering contributions) and |FP| (protein) 
 
During data set collection, mostly three sets at different wavelengths are collected from 
the same crystal. Another popular method used in determining protein structures is the 
SAD phasing. Essential for this method is to break the phase ambiguity by density-
modification techniques. 
 
3.6.6 Model building and refinement 
Based on the initial structure model and using the method of molecular replacement, an 
electron density could be determined. The model and the electron density were then 
used to build in detail the correct protein structure and to insert the water molecules 
which are forming approximately 50% of the solvent content. For this purpose, the 
computer programs COOT and ONO were used [124, 125]. After the complete construction 
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of the desired protein structure model, the computer program Refmac5[121] was used to 
refine the structure by minimizing against the diffraction data. During refmac 
refinement the energy function E which consists of a geometric and a crystallographic 
part is minimized. The result of the refinement is a new structure model. This is 
obtained by recalculating the structure factor amplitude and phase angle. The quality of 
the new structure model is given by the value of crystR which compares the observed 
structure factor amplitude ( )obsF  with the calculated one ( )calcobs FF − : 
( )
∑
∑ −
=
obs
calcobs
cryst F
FF
R
 
In addition to the crystR  there is another R value, called crystR . The calculation of the new 
phases based on the building and refinement can be defective because computer 
programs will try to fit the model under all circumstances, causing over-fitting of the 
model in the electron density. As a cross check, 5% to 10% of the measured reflections 
are excluded from the refinement process and the R value so obtained will be named as 
crystR
 [122]. If the structure building and refinement are correct, the freeR  value must be 
very close to the value of crystR  and decrease with each run of refinement. 
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4. RESULTS AND DISCUSSION 
4.1 Expression of the proteins 
4.1.1 Preliminary tests for the expression 
 
The plasmids resulting from the molecular cloning procedure were transformed for 
expression in the E. coli strain BL21 (DE3) RIL. Cell cultures at the scale of 10 ml were 
prepared for the test expression and induced with 1 mM IPTG or 0.2% α-lactose at a 
cell density of OD600 = 0.6. Before induction and after 4 hours, samples were taken 
from the cultures and lysed in SDS buffer, than loaded on an SDS-PAGE and checked 
for the protein expression level. The induction procedure which resulted in higher levels 
of protein expression was used later in large scale cell cultures. In the work presented 
here, cell cultures induced with 0.2% α-lactose resulted in a higher yield of the protein 
expression in comparison with the cell cultures induced with IPTG. In case of PhzO, this 
was not expressed at all via IPTG induction. The reason for this may be different 
cellular mechanisms that inhibit the protein overexpression by induction with IPTG. 
Another reason could be that the expressed protein is toxic for the host cell so that the 
entire expression machinery is switched off by the cell itself. The expression of the 
proteins used in this work was induced with 0.2% α-lactose at 20 ˚C under continuous 
shaking for at least 24 hours. 
 
4.1.2 Expression and purification of PhzO. 
4.1.2.1 Wildtype PhzO 
The expression was induced under conditions described in section 3.4.2.1. After 
harvesting and disrupting the cells, fractionation of the cytoplasmatic and membrane 
proteins was achieved by centrifugation. The soluble fraction of the desired protein was 
purified by Ni-NTA chromatography (3.4.4). As it is depicted in Figure 32, bands 1 to 
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12, almost pure protein was eluted after contaminations were removed in the “flow 
through” or during the washing steps (not shown in the figure) with up to 40 mM 
imidazole. The binding of the His-Tag to the Ni-beads was already inhibited with 
100 mM imidazole, which caused the elution of the PhzO. Fractions containing PhzO 
were collected and dialyzed over night against dialysis buffer to remove imidazole from 
the protein solution.  
 
Figure 32 SDS-PAGE of the Ni-IMAC for the native PhzO 
 
For the second purification step, PhzO was concentrated to the desired volume and 
applied on the gel filtration column as described in section 3.4.5. 
In the preparative gel filtration, fractions were collected by measuring the absorbance 
at 280 nm and investigated for the presence of proteins. The chromatogram and the 
corresponding gel electrophoresis are shown in Figure 33. The chromatogram shows a 
large product peak corresponding to an elution time between 60 min and 111 min 
(fractions 21-37). This matches with the elution time from the calibration curves of the 
gel filtration column (16/60 HiLoadTM SuperdexTM prepgrade 200) for proteins with a 
molecular weight of about 220 kDa. The native PhzO is eluted as a tetramer and clearly 
separated from a small fraction of aggregated protein (data not shown here). In the 
same figure, the bands 1 to 12 in the gel electrophoresis depict the elution of the 
protein with a molecular weight of 55 kDa, which follows a Gaussian curve typical for 
gel filtration chromatographies. Fractions containing the pure protein were collected 
and concentrated up to the required concentration for protein crystallography, shock  
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frozen in liquid nitrogen and stored at -80 ˚C until next crystallographic and biochemical 
applications. The overall yield of the expression and two step purification of the native 
PhzO is about 20 mg protein per liter of cell culture (20 mg/l). 
 
Figure 33 Preparative gel filtration chromatogram (left) and the associated SDS-PAGE for native 
PhzO (right) 
 
4.1.2.2 Selenium-L-methionine labeled PhzO 
To solve the phase problem involved in the process of structural determination of PhzO, 
a heterologous expression of a selenium methionine derivative of the protein was 
performed. The bacteria were cultured in a minimal growing medium and the required 
amino acids for the suppression of methionine biosynthesis were added to the culture 
right before induction of the protein expression was started with 0.2% α-lactose. At this 
step, 7 amino acids were added into the culture and selenium-L-methionine was added 
instead of methionine. The successful incorporation of the selenium-L-methionine 
aminoacid during the protein biosynthesis offers the opportunity to locate selenium 
atoms by their anomalous scattering. The purification of the PhzO selenium-L-
methionine derivative was similar to the purification of the native PhzO protein, using 
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the two step purification method: Ni-IMAC and size exclusion chromatography. 
PhzO SeMet was expressed and eluted with a high purity of up to 95%, while impurities 
were washed away in the “flow through” fraction and in the washing steps with up to 
40 mM imidazole. The yield of the PhzO SeMet was about 12 mg/l cell culture. 
Eluted proteins were collected and dialyzed over night against dialysis buffer, in order 
to get rid of the imidazole which was mixed with the protein solution during the elution 
procedure. Proteins were concentrated up to a required degree and volume needed for 
the size exclusion chromatography but with regard to the protein stability. The size 
exclusion chromatography was performed as described in section 3.4.5. 
Selenium-L-methionine derivative of PhzO forms a tetramer in the solution. 
After separation of the aggregated protein from the tetramer, fractions containing pure 
protein were collected, concentrated up to three different concentrations and 
immediately used for crystallographic screening. 
 
4.1.3 Expression and purification of TcpA. 
4.1.3.1 Wildtype TcpA  
As described in material and methods, section 3.4., an expression plasmid that 
contained the gene encoding TcpA was transformed in the E. coli strain BL21 (DE3) 
RIL. An isolated colony was pre-cultured over night for inoculating the main culture 
used on the next day for expression. After induction with 0.2% α-lactose, reduction of 
the division rate was observed. During the protein expression for 24 h, only a fourfold 
increase of the cell density could be observed while control cultures reached densities 
equivalent to OD >6. From one liter of culture, 9-10 g cell pellet were obtained. The 
sediment was stored for further processing at -80 ˚C. Before cell disruption with the 
microfluidizer, the cell pellet was resuspended in buffer A and an EDTA-free protease 
inhibitor cocktail was added to prevent proteolytic degradation. The purification was 
similar to that described for native PhzO in section 3.4.4. 
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Fractions containing pure TcpA were collected and concentrated with regard to the 
protein stability. It was observed that TcpA had a slightly different behavior compared 
to PhzO and addition of reducing agents like ß-mercapto-ethanol and up to 10% 
glycerin was required to stabilize the protein during the concentration process.  
As compared to PhzO, TcpA had a lower expression yield, and after the two step 
purification procedure, the total amount of protein obtained was about 14 mg/l culture. 
The protein solution was immediately used for crystallographic screening or stored at 
-80 ˚C for longer time, until biochemical assays were developed and biophysical 
measurements performed. 
 
4.1.3.2 Selenium-L-methionine labeled TcpA 
Cell harvesting, disruption and protein purification were done following the protocols 
used to purify the wildtype TcpA. Figure 34 depicts the SDS-gel electrophoreses with 
the samples taken after induction (column 1), before induction (column 2), “flow 
through” (column 3), the washing step with 40 mM imidazole (column 4) and the 
fractions containing the wanted protein (column 5 to 12), which were eluted from the 
Ni-beads with up to 250 mM imidazole. The protein band at the level of 57 kDa in 
column 3 indicates that probably not all expressed TcpA was bound to the Ni-beads and 
a part of it is still in the “flow through”. A reason for not binding could be an 
unfavorable folding of the macromolecule which could hide the His-Tag and so making 
it inaccessible for Ni-beads. An overloading of the Ni column is excluded as explanation 
since the yield of the protein expression is the lowest from all expressions described in 
this work, up to 8 mg per liter culture, but the methods for the two step purification as 
well the instruments used were the same. 
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Figure 34 SDS-PAGE of the Ni-IMAC for TcpA_Se-Met_Ni-IMAC. 
 
Fractions containing the desired protein solution were dialyzed over night against 
dialyses buffer as described in section 3.4 to get rid of imidazole which could perturb 
the protein stability during concentration and sample preparation for the preparative gel 
filtration. Knowing about the difficulties involved in stabilizing the native form of TcpA 
during the concentration procedure, the protein solution was supplemented by 2 mM ß-
mercapto-ethanol and up to 10% glycerin. The SDS-gel-chromatography shown in 
Figure 35 reveals the high purity of the SeMet labeled TcpA (columns 1 to 10) and its 
clear separation from degradation products as well contaminants with a different 
molecular weight (column 11 and 12). 
 
Figure 35 SDS-PAGE with the fractions collected during the size exclusion chromatography for 
SeMet labeled TcpA. 
 
Although SeMet labeled TcpA was purified in smaller amounts compared with the other 
proteins presented in this work, its purity reached at least 95%. The protein was 
concentrated to various concentrations needed for crystallographic screening 
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experiments and stored and -80 ˚C. It was observed that best crystallographic results 
were obtained with fresh purified protein and before storage at -80 ˚C. 
 
4.1.4 Expression and purification of Fre. 
The monooxygenases described in this study are delivered with reduced FAD by a 
second enzyme, which is the flavin reductase. Until now, no flavin reductase from 
Pseudomonas aureofaciens has been reported, but a previous publication describes a 
successful way of determining TcpA activity with the contribution of the flavin reductase 
from E.coli [97]. For this reason, in all the biochemical assays described in section 4.6, 
the flavin reductase (Fre) is the one belonging to the bacterial genera E.coli and not to 
P. aureofaciens or R. eutropha. The pET7 plasmid encoding the gene of flavin reductase 
(Fre) was obtained from D. Mavrodi from Washington State University, Pullman, USA. 
Fre was expressed in E.coli with overnight induction at 20 ˚C with 0.5 mM IPTG. After 
cell harvesting and cell disruption, the protein solution was loaded on a nickel column, 
washed with 40 mM imidazole and finally eluted with up to 250 mM imidazole, as 
described in section 3.4.4.  
After overnight dialyses of the collected fractions which were containing the desired and 
eluted protein, size exclusion chromatography was performed to separate the 
aggregates from the rest of the protein. The purified Fre was at least 90% pure and 
showed a high activity when used in cross check assays with NAD(P)H (data not 
shown). Fre was concentrated to the required concentration needed for the biochemical 
assays, aliquoted in 50 µl aliquots, deep frozen in liquid nitrogen and stored and -80 ˚C.  
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4.2 Characterization by ESI mass spectrometry 
In order to check whether the labeling of the proteins with selenium-L-methionine was 
successful, the mass of the obtained proteins were analyzed by ESI-MS and compared 
with the mass of the native proteins. The molecular weight of PhzO is 56262 Da and 
contains 14 methionines. Exchanging methionine with selenium-L-methionine yields a 
mass difference of 46,9 Da for each aminoacid which should be measured and in case 
of a complete exchange, the mass of the protein derivative should increase by 662 Da. 
Thus, the expected molecular weight of the PhzO derivative is 56924 Da. The 
measurements shown in Figure 36 depict the mass differences between native and 
labeled PhzO and prove a successful labeling of the enzyme. 
 
Figure 36 ESI-MS measurements for native PhzO (left) with a molecular weight of 56262 Da and 
selenium-L-methionine labeled PhzO (right) with the mass of 56924 Da. 
 
The same measurements were performed for the selenium-L-methionine labeled TcpA. 
The molecular weight of the native enzyme is 58470 Da and the expected mass of its 
derivative is 59132 Da.  
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4.3 Crystallization 
4.3.1 Crystallization of native and selenium labeled PhzO 
In order to determine the suitable crystallization conditions for PhzO, screening 
experiments were performed in 96-well plates at 20 ˚C, as it was described in section 
3.6.2. Native PhzO with various concentrations for up to 22 mg/ml was used to 
determine the initial crystallization conditions. Crystallization screens “PEGs Suite”, 
“PACT Suite” and “Classics” from Qiagen performed best, giving 6 consistent 
crystallization conditions. Some of these conditions were then optimized at a larger 
scale in 24-well plates by varying the concentration of the precipitant, salt and the 
buffer pH. Crystals were grown over a two-week period. The ligand free, native PhzO 
was crystallized in 0.2 M NaBr, 18-20% (w/v) PEG 3350 and 0.1 M bis-Tris pH 7.4-7.7. 
Crystals have a needle like shape with a length of about 120 µm, are colorless and 
mostly single crystals. The crystals are surrounded by protein precipitation, which 
suggests high concentrations of precipitant and protein. By lowering the concentrations 
to prevent protein precipitation, crystals failed to grow. Figure 37 depicts the native 
PhzO crystal. 
 
Figure 37 PhzO native crystals produced in 200 mM NaBr, 18-20% PEG 3350 and 100 mM bis-Tris 
pH 7.4-7.7 (left) and the selenium-L-labeled PhzO crystallized in 1 M LiCl, 0.1 M Bicine 
pH 8.9–pH 9.2, and 8-10%(w/v) PEG 6000 (right) 
 
Selenium-L-methionine labeled PhzO was crystallized in conditions different from the 
native enzyme. In order to define the conditions, a new screening experiment was 
0.02 mm 0.02 mm 
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performed. The best conditions under which SeMet derivative of PhzO was crystallized 
were: 1 M LiCl, 0.1 M Bicine pH 8.9–9.2, and 8-10% (w/v) PEG 6000. These crystals 
grew over night and had a rood like shape as it can be seen in Figure 37. 
 
4.3.2 Crystallization of TcpA and selenium-L-methionine labeled TcpA 
Just as in the case of PhzO, in order to define the initial crystallization conditions, 
screening of the enzyme was made under several different conditions. The native TcpA 
crystallized in 0.3 M NaNO3, 19-21% PEG 3350 and 0.1 M Tris pH 7.1-7.5. Conditions 
had to be optimized several times to obtain single crystals. X-ray diffraction analyses 
showed that crystals lumped together, resulting in double diffraction patterns at certain 
rotation angles, or they tended to reorganize the unit cell so that data processing did 
not gave useful results. A TcpA single crystal is depicted in Figure 38. It has a 
pyramidal shape, is colorless and about 100 µm long. 
 
Figure 38 TcpA native single crystals produced in 0.3 M NaNO3, 19-21% PEG 3350 and 0.1 M Tris 
pH 7.1-7.5(left) and the selenium-L-labeled TcpA crystallized in 0.2 M NaNO3, 19% PEG 
3350 and 0.1 M Tris pH 7.2-7.4(right) 
 
Based on the data set collected for the native and ligand free TcpA crystals and the 
known structure of similar monooxygenases, the structure of the TcpA could not be 
solved by molecular replacement. Therefore selenium-L-methionine labeled TcpA was 
crystallized in similar conditions to that of native protein. Crystals were mostly single 
0.01 mm 0.01 mm 
 
_______________________________________RESULTS AND DISCUSSION 
73 
crystals, colorless and about 40 µm long. Figure 38 shows the native TcpA crystals 
(left) and selenium-L-methionine labeled TcpA (right). 
 
4.3.3 Substrate and cofactor soaks and co-crystallization of PhzO 
To gain insight into the binding of cofactors of PhzO, several soaking and co-
crystallization experiments were performed. All the co-crystallization experiments 
described in this section were performed under similar conditions in which the native 
and ligand free PhzO was crystallized at 20 ˚C. Native crystals were soaked for a time 
span between 5 minutes and 24 h under different conditions with precipitant solution 
containing 0.1-10 mM FAD or 0.1-10 mM PCA. 
 
 
Figure 39 PhzO crystals soaked in a 
solution containing up to 10 mM FAD(left) and 
co-crystallization with 0.1 mM FAD(right). 
 
For co-crystallization, the native enzyme was mixed with FAD, PCA in different 
concentrations ranging from 100 µM to 5 mM. After a short incubation at 4 ˚C to allow 
complex formation, screening protocols were developed and crystallization conditions 
were optimized. The crystallization conditions of the co-crystallization are identical with 
the conditions used to crystallize the native PhzO. The crystals obtained by the co-
crystallization with FAD show irregular shape which points to an increased mosaicity of 
the crystal packing. Figure 39 illustrate the PhzO crystal soaked in an FAD solution 
(left) and the crystals of the assumed PhzO-FAD complex (right) obtained by 
co-crystallization.  
Crystals obtained in the co-crystallization with PCA were very small (up to 15 µm) and 
not diffracting x-rays. Soaking of the native PhzO crystals in PCA solution led to crystal 
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cracking which provides clear evidence that major conformational changes are taking 
place while the substrate forces its way into the catalytically active site of the protein. 
Previous publications show that substrate binding leads to additional conformational 
change in the structure of 4-hydroxyphenylacetate 3-monooxygenase, which is a two 
component flavin diffusible monooxygenase similar to PhzO[128-129]. Crystals obtained via 
co-crystallization with PCA are depicted in Figure 40. 
 
Figure 40 Co-crystallization of the native PhzO with PCA 
 
FAD as chemical compound can be divided into 3 parts: the adenosyl moiety, ribityl and 
the isoalloxazine ring. In order to be able to analyse in detail the binding of FAD to 
PhzO, soaking and co-crystallization experiments were carried out with ADP and FMN. 
Because x-ray analysis of the crystals treated with a solution containing up to 10 mM 
FMN were not showing the expected complex formation, co-crystallization was chosen 
as an alternative method. The protein crystals complexed with FMN appear in small 
number after 7 to 10 days growth, have a regular shape and are yellow in color 
indicating that these crystals absorbed FMN (see Figure 41). The same figure shows 
the crystals of the assumed PhzO-ADP complex. 
0.02 mm 0.02 mm 
 
_______________________________________RESULTS AND DISCUSSION 
75 
 
Figure 41 Co-crystallization of the native PhzO with 5 mM FMN (left) and with 5 mM ADP (right) 
 
In both of the cases, crystals grew under similar conditions as the native PhzO, but 
show different morphology and size. Crystals presented in this section were treated 
with a cryo-protectant that was supplemented with 5 mM of FAD and 5 mM of ADP 
respectively to prevent the complex dissociation while undergoing cryo-protection. 
Then, crystals were shock flash frozen using liquid nitrogen and analyzed by x-ray 
diffraction (chapter 4.5.2). 
 
4.3.4 Substrate and cofactor soaks and co-crystallization of TcpA 
All experiments described in section 4.3.3 were carried out for TcpA as well. TcpA 
crystals are very unstable during the soaking experiments with any kind of ligand, be 
that a cofactor FAD, FMN, ADP or the substrate TCP or the substrate analog DCP. 
Figure 42 shows that crystals treated with an FAD solution of a low concentration (0.5 
mM) cracked. No crystals of the complexed TcpA could be provided for x-ray analysis. 
 
 
Figure 42 Soaking of native TcpA with 0.5 mM FAD. 
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4.4 Structure determinations 
4.4.1 Sequence alignment of PhzO, TcpA and HpaB 
For functional analysis and biochemical characterization of the enzymes, information 
about their 3D structure and a well described catalytically active site are highly 
desirable. Sometimes, hints about the structure and conserved amino acid sequences 
can be obtained just by simple amino acid sequence alignment. In this work, the amino 
acid sequences of PhzO and TcpA were submitted to the data bases of NCBI and PDB 
to search for similar proteins which may have similar structures. Both of the enzymes 
show similarities to the HpaB protein superfamily (Figure 43). The complete sequence 
alignment of PhzO and TcpA with HpaB is attached to the appendix. HpaB is about 25% 
identical and 40% similar to PhzO and TcpA. 
Figure 43 Blast search result. The C-termini of PhzO and TcpA are related to the HpaB superfamily, 
while their N-termini are related to the HpaB_N superfamily. 
 
4.4.2 Data collection, solving and refinement of PhzO 
PhzO native and soaked crystals, as well those coming from co-crystallization, were 
tested using a RIGAKU rotating anode X-ray generator equipped with a MAR Research 
imaging plate detector. The best diffracting crystals were sent to the Swiss Light Source 
(SLS) for X-ray analysis. A data set for the native and the labeled crystals each was 
collected at 100 K as non-overlapping 360° images of 1° oscillation. For native PhzO, a 
dataset with a maximum resolution of 1.7 Å and for the SeMet derivative of PhzO, a 
complete SAD dataset with 2.3 Å at the Selenium-K-edge were collected. Data 
processing revealed that native crystals belong to space group C2221, with unit-cell 
parameters of a = 104, b = 159, c = 114 Å, α = β = γ =90°, while the selenium-L-
methionine labeled PhzO crystals belong to space group P21, with unit-cell parameters 
of a = 103.8, b = 109.7, c = 104.4 Å, α =  γ =90°,  β =99.1°.  The data set of a 
multiple anomalous diffraction contains information about the structure factor of the 
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selenium-L-labeled protein, which combined with the integration results of the native 
data set, allows the phase determination of the native protein. Based on the anomalous 
signal, the Patterson map was calculated and the position of all selenium atoms was 
determined. The structure of PhzO was determined with AutoSharp, manually built in 
COOT to introduce minor adjustments and refined in REFMAC5. At the end of the 
refinement, the TLS option in REFMAC5 was employed as this produced lower Rfree 
values[125]. The statistics of data collection and refinement are summarized in table 4-1. 
Table 4-1 Data collection statistics for PhzO and PhzO_SeMet 
 NATIVE - PhzO Se-SAD – PhzO 
Data collection   
Space group C2221  P21 
Cell dimensions   
  A, b, c (Å) 104, 159, 114; 
        
104, 110, 104 
          α, β, γ (°) 90, 90, 90 90, 99, 90 
Wavelength 0.97886 0.97915 
Resolution Å 50 - 1.75 (1.85 – 1.75) 20-2.3 (2.4-2.3) 
Rsym(I) 10.9  9.7 
Rmerge(F) 8.4 (43.1) 10.7 (37) 
I / σ(I) 22.2 (4.1)  12.0 (4.5)  
Completeness (%) 100 (100) 100 (99.9) 
Redundancy 7.5 (7.5) 3.9 (3.9)  
   
Refinement   
Resolution (Å)            
(Highest Shell) 
  
50 - 1.75 (1.80 – 1.75) 
(1.80 – 1.75) 
 
No. reflections 90276 (7007)   
Rwork 14.8 (17.9)  
Rfree 19.1 (24.8)  
No. atoms   
  Protein 7688  
  Ligand/ion 88  
  Water 773  
B-factors   
  Protein 19.37  
  Ligand/ion -  
  Water 31.55  
R.m.s deviations   
  Bond lengths (Å) 0.024  
  Bond angles (°) 1.946  
Values in parentheses refer to the highest resolution shell.          
Rsym(I) = ΣΣ I(h)j - <I(h)> / ΣΣ I(h)j, where I(h)j is the measured diffraction intensity, and the summation includes all observations. 
Rmerge(F) is a redundancy-independent merging R-factor of structure factor amplitudes 
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The Ramachandran plot (see appendix) obtained after complete building and 
refinement shows 96.65% of the total amino acids in the preferred region, 1.89% in the 
allowed region and 1.47% in the outliers. 
 
4.4.3 Data collection, solving and refinement for PhzO complexed with FAD 
The native PhzO crystals soaked with FAD posses a lower symmetry of P21 compared to 
the space group of the native PhzO which is C2221. In contrast, data taken from the 
latter crystals were anisotropic. This indicates that their crystal packing was disturbed 
by the incorporation of FAD, while the native crystals on their own showed a good 
diffraction up to 1.7 Å.  
Stable crystals were obtained when crystals grown via co-crystallization with ADP were 
soaked with FAD. In these crystals as depicted in Figure 41 protein was packed in the 
orthorhombic space group C2221. The crystals were diffracting up to 3.2 Å. The 
corresponding data collection record is summarized in Table 4-2. 
Table 4-2 Data collection statistics for PhzO complexed with FAD 
 PhzO - FAD 
Data collection  
Space group C2221  
Cell dimensions  
  A, b, c (Å) 103.61, 174.56, 110.97 
          α, β, γ (°) 90, 90, 90 
Wavelength 1.036763 
Resolution Å 50 – 3.2 (3.3 - 3.2) 
Rsym(I) 7.1 (23.7) 
Rmerge(F) 10.5 (46.7) 
I / σ(I) 20.4 (4.4) 
Completeness (%) 99.9 
Redundancy 7.4 (7.5) 
  
Refinement  
Resolution (Å)            
(Highest Shell) 
  
50 – 3.2 
(3.28 – 3.2) 
No. reflections 16122 (1253) 
Rwork 19.4 (31.0) 
Rfree 25.4 (37.6) 
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No. atoms  
  Protein 15399 
  Ligand/ion 106 
  Water 0 
B-factors  
  Protein 55.19 
  Ligand/ion 81.14 
  Water - 
R.m.s deviations  
  Bond lengths (Å) 0.011 
  Bond angles (°) 1.339 
Values in parentheses refer to the highest resolution shell.  
Rsym(I) = ΣΣ I(h)j - <I(h)> / ΣΣ I(h)j, where I(h)j is the measured diffraction intensity and the summation includes all observations. 
Rmerge(F) is a redundancy-independent merging R-factor of structure factor amplitudes 
 
4.4.4 Data collection, structure determination and refinement of TcpA 
Single crystals of the native TcpA were chosen for in-house diffraction tests and the 
best diffracting crystals were sent to the Swiss Light Source for data collection. A data 
set with a maximum resolution of 2.9 Å was collected. Data processing revealed that 
native TcpA crystals belong to space group C2221, with unit-cell parameters of a = 126, 
b = 150, c = 231 Å, α = β = γ =90°. However, the structure of TcpA could not be 
determined by molecular replacement.  
In order to determine the structure of TcpA by the method of single/multiple anomalous 
diffraction, crystals of the selenium-L-methionine labeled TcpA were crystallized and 
analyzed by x-ray diffraction. These crystals diffracted up to 3 Å and belong to space 
group P21, with unit-cell parameters of a = 99, b = 228, c = 98 Å, α = γ = 90°, β = 
100°. Based on the anomalous signal, the Patterson map was calculated and the 
position of all selenium atoms was determined. The program SHARP was then used to 
calculate the initial protein phase, using the f’ and f’’ values determined experimentally. 
The resulting electron density was of poor connectivity, making tracing of the structure 
impossible. However, the data collected from the selenium-L-methionine labeled crystal 
was consistent enough to determine the protein structure by molecular replacement, a 
procedure that failed with the native TcpA dataset. REFMAC5 was used for automatic 
rigid body refinement and for several iterations of TLS (translation, libration, screw-
rotation displacement) refinement. The statistics are summarized in table 4-3. 
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Table 4-3 Data collection statistics for TcpA and TcpA_SeMet 
 NATIVE - TcpA Se-SAD - TcpA 
Data collection   
Space group C2221  P21 
Cell dimensions   
  A, b, c (Å) 126, 150, 231 96.3, 230.9, 98.0 
  α, β, γ (°) 90, 90, 90 90, 99.7, 90 
Wavelength 0.978 0.9791 
Resolution Å 20-2.9 (2.9) 20-2.8 (2.8) 
Rsym(I) 6.3 (55.8) 27.6 (46.9) 
Rmerge(F) 10.8 (51.8) 8.9 (43.3) 
I / σ(I) 13.99 (2.51) 13.6 (3.7)  
Completeness (%) 99.9 99.5 (99.9)  
Redundancy 2.6 3.8 (3.9) 
   
Refinement   
Resolution (Å)            
(Highest Shell) 
  
20-2.8 
(2.8) 
 
No. reflections 245301 (39848)   
Rwork 0.25  
Rfree 0.18  
No. atoms   
  Protein 30432  
  Ligand/ion -  
  Water -  
B-factors   
  Protein 55.37  
  Ligand/ion -  
  Water -  
R.m.s deviations   
  Bond lengths (Å) 0.014  
  Bond angles (°) 1.510  
Values in parentheses refer to the highest resolution shell.          
Rsym(I) = ΣΣ I(h)j - <I(h)> / ΣΣ I(h)j, where I(h)j is the measured diffraction intensity, and the summation includes all observations. 
Rmerge(F) is a redundancy-independent merging R-factor of structure factor amplitudes 
 
The accuracy of the final model of TcpA is represented by the Ramachandran plot (see 
appendix) obtained after complete building and refinement. This shows 92.89% of the 
total amino acids in the preferred region, 4.96% in the allowed region and 2.16% in the 
outliers. 
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4.5 Structural and functional analysis of the monooxygenases 
4.5.1 Structure of PhzO 
PhzO is composed of four identical subunits and thus has an overall molecular weight of 
about 220 kDa. The structure of the PhzO is a dimer of dimers and is shown in Figure 
44.  
 
Figure 44 Crystal structure of PhzO as tetramer (left) and the crystal structure of the dimeric 
subunit of PhzO with the active site marked (right) 
 
One monomer consists of 14 α-helices placed in the N-terminal and C-terminal domains 
and 14 β-sheets in the middle domain. In addition, each monomer has a C-terminal α-
helical tail, which protrudes from the monomers of a dimer and extends over the other 
dimer. Between the C-terminal and the middle domain, which is comparable to a barrel 
formed by β-sheets, a major groove can be seen, which serves as binding site for 
FADH2 and the substrate PCA. 
The monomers, depicted in Figure 45 have three main domains: the N-terminal (aa 
10-149 red), middle (aa 150-283 green), and C-terminal (aa 284-472 blue), which ends 
with the α-helical tail (aa 473-491 orange). 
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Figure 45 The monomer PhzO, subdivided in 3 domains marked with red (aa 1-149), green (aa 
150-283), blue (aa 284-472) and in orange the α-helical tail (aa 473-491). 
 
4.5.2 Structure of PhzO in complex with FAD 
The crystal packing allows 4 monomers in the asymmetric unit arranged as two dimers. 
The evaluation of the x-ray diffraction showed additional electron density in the active 
site of PhzO, which can not be rationalized as that of the protein backbone. This is 
probably due to the fact that FAD is not stable upon irradiation by X-rays, which is 
supported by the fact that the crystals turned black during data collection. As a 
consequence FAD, which is responsible for the additional electron density, is depleted in 
quantity, and this may in turn contribute to the resulting decreased electron density. 
Initial electron density maps showed FAD bound to the protein, but not in an accurate 
conformation. Clear electron density maps were calculated for the AMP and ribityl 
moieties but not for the isoalloxazine ring (see Figure 46). In order to reduce FAD, the 
isoalloxazine ring is solvent exposed and therefore flexible. The flexibility of the ring 
scales up the difficulty in determining its electron density.  
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Figure 46 Fo-Fc electron density map of the PhzO-FAD crystal structure. The map is shown in black 
and FAD is colored differently depending on the element (C green, N blue, S orange, O red). 
 
The space group of PhzO crystals in complex with FAD is C2221, the same as 
determined for the native PhzO crystals. The overall structure of the PhzO-FAD complex 
is similar to that of the ligand free form, with r.m.s.d. of 0.709 Å for 491 Cα atoms. 
Except for a few minor details, these two protein structures are identical, and the 
binding sites show no significant differences. This suggests that binding of FAD to PhzO 
did not lead to any conformational changes, as was originally speculated based on the 
findings on the related HpaB protein structure (see chapter 1.9).  
When FAD binds to the active site of native HpaB, the loop Q148 - Y162 closes the 
entrance of the active site and contributes to ligand fixation. The residue Q148 rotates 
and thereby makes more space for the isoalloxazine ring moiety of FAD. On the other 
side of the pocket, R447 comes in proximity to the AMP moiety of FAD and forms 
hydrogen bonds with it (Figure 47). 
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Figure 47 Comparison of the 
native monomer HpaB structure 
(magenta) with the structure of 
HpaB-FAD complex (green). The FAD 
molecule is highlighted in green. 
 
 
 
Overlaying the structure of a similar monooxygenase in complex with FAD (HpaB) with 
the structure of PhzO-FAD confirmed the approximate position for the AMP and ribityl in 
the PhzO protein, but the position of the isoalloxazine ring still remained unclear. FAD 
was not found in the elongated phase orientated deeper towards the catalytic site, but 
instead coiled on the surface of the protein (see Figures 48 and 49). A possible 
explanation for the same could be, experiments were performed with the oxidized form 
of FAD, since the reduced form is highly unstable and thus the isoalloxazine moiety was 
not able to bind the active site of the protein. 
 
 
 
Figure 48 The structure of HpaB-FAD 
overlapped with the structure of PhzO-FAD. The 
active site of HpaB in complex with FAD 
(magenta). The FAD depicted in green is bound 
to PhzO. 
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Based on the refined protein complex structure, the location of FAD in the active site 
and its interactions with the aminoacid residues were analyzed in detail. The results are 
depicted in Figure 49. Only a few hydrogen bonds are formed between the residues 
and the ligand. FAD binds to Q161 and R166 of the chain A and to Q397 and E393 of 
the neighboring chain B. All these interactions are exclusively with the ADP moiety. The 
question still remains whether these few interactions are enough to facilitate the 
binding of FAD to the active site of the enzyme.  
 
Figure 49 The aminoacids which interact binding FAD (orange) to the active site of PhzO (chain A 
magenta, chain B green). 
 
Findings from the structural determination of the protein complex are in contradiction 
with some results from the ITC measurements, which led to the conclusion that the 
isoalloxazine moiety, and not ADP, is responsible for the binding of FAD to the protein. 
Because this protein complex structure did not yield decisive clues about the position of 
FAD in the active site of PhzO, modeling experiments were carried out comparing the 
active sites of PhzO and HpaB (chapter 4.6). 
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4.5.3 Structure of TcpA 
The output of the refinement with the software REFMAC5 is shown in Figure 50. 
Compared to PhzO, which crystallized as one dimer of dimers, the asymmetric unit of 
the TcpA crystals contains 8 monomers arranged as two dimer of dimers. 
 
igure 50 Crystal structure of TcpA. A total of 8 monomers are occupying the unit cell. The 
monomers marked in yellow, green, cyan and magenta are forming the first dimer of 
dimers (left). The second dimer of dimers contains the chains highlighted in orange, 
rose, blue and gray (right) 
 
The tertiary structure of TcpA is very similar to the structure of other monooxygenases 
from the same protein superfamily, such as PhzO and HpaB. Structural analysis 
revealed that TcpA has the same three domain composition as PhzO: the N-terminal (aa 
1-146 red), middle (aa 147-274 green), and C-terminal (aa 275-472 blue), which ends 
with the α-helical tail (aa 473-480 orange), see Figure 51. 
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Figure 51 The monomer of TcpA with its four 
domains highlighted in red, green, blue and orange. 
 
 
 
Unfortunately, the resolution of 3.0 Å is not sufficient enough in order to determine the 
exact position of some of the loops. Although the individual refinement of all eight 
chains and the superimposure of the monomers were of great help in determining the 
structure of flexible loops, some amino acids are still missing. Thus, amino acid residues 
S157-S169 forming the loop in the green middle domain (see Figure 52) could not be 
associated with any electron density and so they could not be defined in the structure 
model. These residues are not directly involved in the catalytically active site of the 
protein, but the loop is more or less like a lid that closes the binding pocket, as was 
shown in Figure 47 for HpaB.  
 
 
Figure 52 Superimposition of the TcpA chains 
(various colors) and PhzO (blue) are showing the 
interruption in the very flexible loop. PhzO suggests 
what the loop in the case of TcpA might look like. 
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4.6 Modeling 
In order to get insights into the binding of potential ligands of PhzO and TcpA, their 
resulting structures were compared to that of the related protein from T. thermophilus 
HB8 HpaB[124]. For this purpose, the software PyMOL and MAESTRO were used to 
overlay both protein structures and analyze the structural differences. The structure of 
HpaB in complex with the cofactor FAD is shown in Figure 53. As it can be recognized 
from the figure, the active site is widely open and thus the cofactor FAD can bind into 
it. First it was analyzed in detail how the FAD binds into the active site of HpaB by 
determining the hydrogen bounds which are formed between the amino acid residues 
and the cofactors. 
 
Figure 53 Structure of the active site of HpaB (green) in complex with FAD (magenta) 
 
FAD binds to HpaB by eight hydrogen bonds with the amino acid backbone, seven with 
the amino acid side chains and eight with water molecules. FAD has an elongated shape 
and lies within the binding pocket, which is formed by the following amino acids: R100, 
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Y104, H142 to R151, T183 to T185, D247 and R433 to R447 (see Figure 54). The 
pocket gains additional stability by some of the amino acid residues of the adjacent 
monomer: A312 to V318 and Q378 to S382 (data not shown). These amino acids form 
hydrogen bonds with the ADP moiety of FAD. 
 
Figure.54 Interaction between the amino acid residues of HpaB (green) and FAD (magenta) 
 
The comparison of the TcpA and PhzO with HpaB of T. thermophilus HB8 in complex 
with FAD (PDB ID: 2YYI) was expected to show which amino acids could be responsible 
for the binding of FAD in the active site of PhzO and TcpA, respectively. 
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Figure 55: Amino acid residues assumed to interact with FAD (magenta) in the active site of PhzO 
(green) 
 
By assuming that the position of FAD in PhzO is similar to that in HpaB, the following 
amino acids are likely to be involved in the formation of the binding site for FAD: R109, 
T156 to R166, T202, E263 and R450 to S461. 
The structure of HpaB in complex with FAD and its substrate 4-hydroxyphenylacetate 
(4-HyPhAc) was used as a model for docking experiments with PCA and PhzO. These 
suggest that PCA occupies a similar position in the catalytically active site of PhzO as in 
the case of 4-hydroxyphenylacetate in HpaB. Figure 56 shows the position of FAD and 
PCA complexing PhzO. In addition, the aminoacids involved in binding the lingands are 
highlighted, and black dashes represent the polar contacts formed between atoms. 
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Figure 56: Docking of FAD (green) and PCA (green) in the PhzO molecule (green). The polar 
contacts between amino acids, FAD and PCA are marked with black dashes. The 
highlighted picture is showing a superposition of PCA over the substrate of HpaB, 4-
HyPhAc (magenta). 
 
Even though PCA is a three ring system compared with 4HPA which has just one ring, 
their positions match accordingly to the docking experiments. In order to transfer a 
hydroxyl group on the C2 atom of the substrate, PCA must be in the proximity of the 
C4α atom of the isoalloxazine ring. The docking revealed that C2 atom of PCA and C4α 
of the FAD are in opposite directions which would prevent a successful transfer of the 
hydroxyl group. Further docking experiments were carried with PCA and FAD in order to 
find a better position for PCA, which would allow the hydroxylation taking place. 
An additional position of PCA was found (Figure 57) between the last α-helix of the 
C-terminal domain (blue) and the loop E240-R263 (red) of the middle domain. It seems 
that the active site of the enzyme is closed at its ends by two loops. Similar to HpaB, in 
PhzO the loop P160-M182 (red) should be responsible for the FAD stabilization in the 
binding pocket. While P160-M182 acts like a lid for the FAD binding site, the loop 
E240-R263 it may be involved in the substrate fixation and product release. The actual 
position of PCA is in the immediate proximity of the isoalloxazine ring and such 
orientated that the C2 atom of PCA is 6.47 Å apart from the C4α atom of the 
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isoalloxazine ring. Soaking experiments of native PhzO crystals with the substrate PCA 
were unsuccessful because of crystal cracking, which is mainly induced by 
conformational changes. If the loop E240-R263 plays a role in substrate-product 
exchange, this would probably lead to conformational changes and explain crystal 
cracking while soaking experiments. 
 
Figure 57: Docking of FAD and PCA in PhzO. Left: the loops P160-M182 and R240-E263 (red) 
probably stabilize the cofactor FAD and substrate PCA, respectively. Both loops are a part 
of the middle domain (green). The binding pocket is between the middle domain (green) 
and C-terminal domain (blue) and closed by two loops. Right: The measured distance 
between C2 atom of PCA and C4α of FAD is 6.47 Å. 
 
Furthermore, the second docking experiment described here shows that PCA forms a 
hydrogen bond with the amino acid residue T202, in contrast to the first docking 
experiment, were PCA was not forming any hydrogen bond with the residues of the 
main chain. 
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HpaB in complex with FAD and 4-HyPhAc were used as model for docking FAD and TCP 
in the active site of TcpA. The resulting TcpA structure in complex with both ligands is 
depicted in Figure 58. 
 
 
Figure 58: Docking of FAD (green) and TCP (cyan) in the TcpA molecule (magenta). The polar 
contacts between amino acids and FAD are marked with black dashes. The highlighted 
picture is showing a superposition of TCP over the substrate of HpaB, the 
4-hydroxyphenylacetate (yellow). 
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Measurements were influenced by the lack of the S157-S169 loop, which in case of 
PhzO is involved in the binding of FAD. Unfortunately just three hydrogen bonds were 
determined for binding FAD using the docking procedure.  As already mentioned before, 
the hydrophobicity of TCP should induce large hydrophobic interactions with the 
enzyme. Although FAD and TCP are positioned in TcpA similar to FAD and 4-HyPhAc in 
HpaB, their real location in the catalytically active site of TcpA remains uncertain. The 
only chance to obtain a clearer view of the active site occupancy for both of the 
enzymes is to crystallize them in complex with the ligands and analyze them using x-ray 
diffraction. As it was reported in the section dedicated to crystallization, soaking and co-
crystallization experiments were unsuccessful. However, docking and modeling the 
ligands in the active site of the enzymes made it possible to determine their 
approximate position and gave a hint about the number and type of aminoacids that 
could interact with them. In order to determine the exact type of aminoacids which are 
involved in substrate and cofactor binding, mutant proteins which include modifications 
in the structure of the active site must be biosynthesized and used in biochemical 
assays to monitor the reaction turnover. 
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4.7 Ligand affinity measurements 
The following describes the results of measurements concerning the affinity of the 
enzymes PhzO and TcpA for different ligands. For isothermal calorimetric titration, the 
ligands FAD, FMN, ADP, AMP, PCA, 2OHPCA, TCP and DCP were used. 
 
4.7.1 Preliminary test for buffer contribution 
The preliminary tests must reflect whether the substrate samples can be transferred 
into comparable buffer conditions like in the ITC experiment without allowing the 
release of dilution heat. While PCA is very well soluble in water, this is not the case for 
the 2OHPCA, TCP and DCP without the addition of 20% DMSO. In the ITC 
measurements in general, the reactants are used in a concentration ratio of about 10:1. 
In a test run, 20% DMSO substrate-buffer solution and protein-buffer solution (in which 
the proteins are eluted) were titrated to each other. In the syringe was the buffer 
solution, supplemented with 20% DMSO, and in the template the buffer solution only. 
The measurement showed strong dilution effects caused by the release of dilution heat 
and associated entropy changes. Due to this result, difficulties were to be expected in 
the later measurements when ligand is titrated to the protein solution. 
 
4.7.2 Preliminary tests for determining the titration parameters 
Another parameter that affects the signal amplitude and the quality of the 
measurement is the speed with which the reaction equilibrium is reached after injection 
occurs. If the reaction is fast, this leads to a rapid heat release and thus to a large 
signal amplitude. For these preliminary experiments, 50 µM of Protein and 500 µM of 
ligand were used. The proteins were dialyzed overnight against 150 mM NaCl, and 10 
mM Tris at pH 8.00 at 4 ˚C. After the protein solution out of the measuring cell had 
reached initial thermal equilibration, the titration started by injecting the ligand in 
increments of 2 µl within 5 seconds. Because of technical constraints, the first dose is 
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only 0.2 µl. Between each injection, the waiting time for recording the signal is 60 
seconds. In the first experiment performed at 5 ˚C, weak signal amplitudes were 
observed after injection. Increasing the temperature to 20 ˚C had the consequence that 
the signal strength increased significantly after each injection. The integration of the 
signals shows, however, no plausible value for the heat change detected. The main 
reason for that was the waiting time, since 60 seconds did not appear to be sufficient, i. 
e.  the detected signal had not enough time to decay to the starting level before the 
next injection occurred. The waiting time was extended to 4 minutes and the 
concentration of protein and ligand were increased up to 400 µM and 4 mM 
respectively, in order to allow an accurate determination of the binding affinity. 
 
4.7.3 Binding affinity measurements with FAD, FMN, ADP, AMP and PCA 
The evaluation of the ITC measurements carried out in studying the interaction of PhzO 
with FAD is shown in Figure 59. 
 
Figure 59 ITC measurement of 400 µM PhzO titrated with 4 mM FAD 
 
In the upper part of the figure, the heating power provided by the calorimeter is plotted 
versus reaction time. The negative heat output shows that the reaction in which PhzO 
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binds FAD is an exothermic. As the figure shows, the heat output decreases stepwise 
until no more free enzyme is available and saturation of the protein solution is 
achieved. In the lower part of the same figure, the heat required for one mol of ligand 
was plotted versus the molar ratio of the ligand to enzyme. Here, a sigmoidal curve was 
obtained. The analysis provided the following data for the binding of FAD to PhzO: 
Stoichiometric coefficient N = 1.14 ± 0.0174 sites  
Association constant K = 7.71 • 104 ± 1.45 • 104 M-1 KD = 1/K = 13 µM  
Enthalpy   ΔH = -1132 ± 24.13 cal mol-1 
Entropy   ΔS = 18.6 cal/mol/deg 
The calculated stoichiometric coefficient of a PhzO-FAD complex is close to 1, as it was 
to be expected, since each monomer has an active site and thus can bind one molecule 
of FAD. This result is a positive indication for the accuracy of the fitted curve. The 
dissociation constant of the complex is 13 µM and the reaction enthalpy is about -4.7 kJ 
mol-1, which is in the order of van der Waals bonds. The successful fitting of the data 
shows that FAD binds to PhzO, even if this bond is relatively weak. 
To investigate which part of the FAD is required for the binding to PhzO, additional ITC 
measurements were carried out with AMP and ADP. Because both of the measurements 
show similar results, just the one for ADP is shown in Figure 60 as an example.  
 
 
       
  
Figure 60 ITC measurement of 115 µM PhzO titrated 
  with 1.15 mM ADP 
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In the upper part of the Figure 60 no trend of the heating power is discernable, and 
signals are very small on a scale from 0 μcal s-1 to -0.08 μcal s-1. Even with further 
experiments at higher enzyme and ligand concentrations, no trend of the exothermic 
peaks could be detected. This suggests that between ADP and AMP on one hand and 
PhzO on the other hand no interaction or no detectable binding occurs. 
Because ADP and AMP were not binding, further ITC measurements were carried out 
with FMN, which stays for the isoalloxazine ring and the ribityl moiety of FAD. The 
results are shown in Figure 61. 
 
Figure 61 ITC measurement of 270 µM PhzO titrated with 2.7 mM FMN 
 
In contrast to the AMP and ADP measurements, here a clear trend became apparent. 
The analysis yielded the following results: 
Stoichiometric coefficient N = 2.08 ± 0.107 sites 
Association constant K = 1.85 • 104± 7.62 • 103 M-1 KD = 1/K = 54 µM 
Enthalpy   ΔH = 700.6 ± 35.05 cal mol-1 
Entropy   ΔS = 21.3 cal/mol/deg 
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While the binding of FAD is exothermic, here the heating power input is positive, 
suggesting an endothermic reaction, which is reflected in the positive value of the 
reaction enthalpy of 2.9 kJ/mol-1. This may suggest that during the binding of FMN 
conformational changes of the enzymes are taking place and heat must be absorbed. 
However, this raises the question why this result is different from the one obtained in 
the experiments performed with FAD. It may be possible that a conformational change 
of the enzyme is also induced by the binding of FAD, but there are larger exothermic 
contributions from FAD in contrast to those of FMN. The stoichiometric coefficient of 
about 2 points out that one ligand molecule binds to two catalytically active sites. A 
measurement error is unlikely because a repetition yielded similar results. An incorrect 
fitting of the curve could be possible because the heating power did not decrease to 
zero, showing that saturation of the enzyme was not yet achieved. Therefore, the ITC 
measurement was repeated with the twofold FMN concentration and again, a very 
similar result was obtained (data not shown). From the data obtained from the ITC 
measurements it can be concluded that an interaction between FMN and PhzO 
occurred, but led to conformational changes in the enzyme. This assumption is 
supported by current knowledge about the mechanism in the PhzO related enzyme from 
T. thermophilus HB8 HpaB. Here, mainly the isoalloxazine ring and only to a small 
extent the ADP portion of FAD are responsible for the binding to the enzyme. Binding of 
FAD changes the conformation of the HpaB so that the active site becomes accessible 
for molecular oxygen and the actual substrate[43, 125]. 
It is known from previous publications that the reduced form of FAD and FMN has a 
higher affinity towards the monooxygenases than their oxidized forms [126,127]. ITC 
measurements in anaerobic conditions with the reduced form of these compounds were 
not performed. 
To determine the affinity of the substrate PCA to the enzyme PhzO, ITC measurements 
were carried out with a set of different concentrations and variations of the 
ligand / enzyme ratio. 2.5 mM of PCA were titrated to 250 µM PhzO and the results are 
shown in Figure 62. 
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Figure 62 ITC measurement of 250 µM PhzO titrated with 2.5 mM PCA 
 
Stoichiometric coefficient N = 0.154 ± 0.07 sites 
Association constant K = 3.92 • 104± 5.28 • 103 M-1 KD = 1/K = 25.5 µM 
Enthalpy   ΔH = -3.98 • 104 ± 7.4 cal mol-1 
Entropy   ΔS = 121 cal/mol/deg 
 
The value for KD is 25.5 µM which indicates that PCA binds to the enzyme but very 
weakly. The reason for that could be that PCA is produced in vivo in the reduced form, 
and this could show a better affinity to the enzyme. The stoichiometric coefficient of 
0.15 indicates that maybe PCA was not stable during the titration. The precipitation of 
the ligand leads to changes in the molar ratio, which influence the correct calculation of 
the stoichiometric coefficient. Measurements with reduced PCA were not performed for 
the simple reason that reducing agents used to reduce PCAox to PCAred would lead to 
dilution effects which would overshadow useful data detection. Adding the reducing 
agent to the protein solution led to slight protein precipitation.  
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4.8 Enzyme assay and HPLC-APCI-MS measurements 
4.8.1 Measurements for PhzO 
The turnover of the reaction catalyzed by PhzO was monitored by HPLC-APCI-MS 
measurements. It was not possible to monitor the reaction by simple photometric 
approaches because the absorption maxima for PCA is at 248 nm and 371 nm, which 
are very close to that of 2OHPCA at 257 nm and 369 nm[33]. 
Educt and product concentrations were monitored over a time period of up to 20 
minutes. A decrease of substrate concentration was recorded, while the concentration 
of the product was increasing. The characteristic retention time peaks for the substrate 
PCA and product 2OHPCA were integrated using the software Xcalibur, and the 
resulting values were divided by the area of the caffeine peak. This served as a 
reference value in the integration process, because the caffeine concentration does not 
change during the reaction. For a detailed description of the procedure, see section 
3.5.2.2. Due to a possible spontaneous decarboxylation of 2OHPCA to 2OHPHZ, the 
measurements were scanned for both compounds. Below the results are presented 
concerning PCA consumption and 2OHPCA formation. 
Preliminary experiments were performed to determine which form of PCA and which 
FAD concentration is most favorable to study the reaction catalyzed by PhzO. Figure 
63 shows that the reduced form of PCA is consumed in bigger amount by PhzO than its 
oxidized form. Even if the reaction was monitored for 50 minutes, unfortunately the 
complete substrate consumption was not achieved. 
 
Figure 63 HPLC-APCI-MS 
measurements with PCAred and PCAox 
as substrates. The reduced form of 
PCA is consumed more than its 
oxidized form. 
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Parallel to the substrate consumption, the product formation was also monitored. The 
chart in Figure 64 shows the formation of different products, dependent on the 
substrate type that was used in the assay. 
 
Figure 64 HPLC-APCI-MS measurements showing the product formation, 2OHPCAox (red) and 
2OHPCAred (blue) 
 
The increase in 2OHPCA is not as strong as the decrease in PCA, but still clearly 
discernable. Due to a decrease in the concentration of PCA and the simultaneous 
increase in the concentration of 2OHPCA, the reaction of PCA to 2OHPCA is confirmed 
by PhzO. Trying to optimize the conditions, various FAD concentrations were chosen to 
perform a new set of measurements. By varying the concentration of FAD in the range 
from 250 to 1000 µM, measurements did not indicate any significant change in product 
formation. All the assays performed in this work were done in the presence of 1 mM 
FAD. Results are presented in Figure 65. 
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Figure 65 HPLC-APCI-MS measurements with various FAD concentrations. Comparable 2OHPCA is 
generated independent on the FAD concentration. 
This optimization is important because a high concentration of FAD could inhibit the 
activation of the monooxygenase and decrease the substrate turnover. 
Despite much effort, it was not possible to run the reaction until complete substrate 
consumption. Just about 10 to 20% of the substrate was used up even if a higher 
concentration of enzyme was added to the reaction mixture (see Figure 66). 
 
Figure 66 HPLC-APCI-MS measurement showing substrate concentration decrease and 
simultaneous product formation 
 
PhzO could not only produce 2OHPCA but also other phenazine derivatives and this may 
explain why more PCA is consumed than 2OHPCA is produced. The measurements 
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presented in this work could not show any significant formation of other phenazine 
derivatives. 
In order to increase the reaction yield, it was tested whether NADPH or NADH is a 
better electron donor in the oxido/reduction reaction catalyzed by the flavin reductase 
Fre. Because Fre is the flavin reductase component of the two-component 
flavin-diffusible system, its properties to produce and deliver FADH2 may be relevant. 
Reaction assays supplemented by NADH were performing better than those by NADPH. 
The overall reaction yield measured on the base of 2OHPCA is shown in Figure 68. 
 
Figure 68 HPLC-APCI-MS measurements showing the increase of 2OHPCA dependent on the 
cofactors NADH and NADPH. The reaction yield is higher when NADH is used instead of 
NADPH. 
 
By increasing the concentration of the enzyme, a higher product formation was 
observed in the first 5 minutes, after which no further product release has been 
detected. It was concluded that the reaction catalyzed by PhzO ends after 
approximately 5 minutes, as it can be seen in the chart shown in Figure 67. 
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Figure 67 HPLC-APCI-MS measurement with various concentration of PhzO on the base of 2OHPCA. 
The more enzyme is added, the more 2OHPCA is formed in the first 5 minutes. 
 
It is assumed that reaction stops basically after 5 minutes because of lack of reduced 
FADH2. An explanation for the very low reaction efficiency could be that the transfer of 
the reduced flavin from the reductase to the monooxygenase is not efficient enough, so 
that FADH2 is oxidized to FAD instead of being used up by PhzO. 
It is important to note that we used the flavin reductase from E.coli, instead of the 
reductase of P. aureofaciens, which is not yet known. Furthermore, reactions were 
carried out under aerobic conditions since the monooxygenase needs molecular oxygen 
to be transferred into the substrate molecules. The presence of O2 is essential for the 
monooxygenase but it interferes with the stability of FADH2 which can be easily oxidized 
to FAD with concomitant release of H2O2. 
 
4.8.2 Measurements for TcpA 
Similar enzyme assays were performed and HPLC-APCI-MS measurements were carried 
out for TcpA, by using the actual substrate TCP but also the substrate analog DCP. In 
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none of the cases, measurements ended with concluding results. A real substrate 
concentration decrease concomitant to product formation could not be recorded. 
 
4.9 Photochemical reduction of FAD 
The biochemical assays described in the previous chapter could not confirm complete 
substrate consumption. A reason could be the inefficient transfer of the reduced FAD 
from the flavin reductase to the monooxygenase. In order to overcome this, anaerobic 
photochemical reduction of FAD by light and EDTA was carried out.  
FAD with 250 mM EDTA was exposed to a light source of at least 100 W under 
anaerobic conditions. The change in color, from yellow to colorless indicates the 
successful reduction of FAD. Unfortunately, while supplementing the reduced FAD 
solution with the monooxygenase and the substrate, the reduced FAD undergoes 
spontaneous oxidation. Exposing the reaction mixture again to the anaerobic 
photochemical reduction, results in a colorless solution but the substrate turnover could 
not be detected. The relatively high concentration of EDTA could be a disturbing 
parameter in the reaction catalyzed by the monooxygenase, but also the absence of O2 
since the photochemical reduction requires anaerobic conditions.  
 
4.10 Difficulties in dealing with monooxygenases 
Monooxygenases are a class of enzymes that are difficult to handle. PhzO and TcpA 
pose numerous challenges whether it is over-expression, protein purification, protein 
crystallization or biochemical assays. The heterologous expression and isolation of 
monooxygenases was shown to be very difficult in some cases, either because they 
may be toxic for the expression in host cell or because they are multicomponent 
enzymes which are difficult to stabilize[21]. The work presented here describes two 
strategies for induction of protein over expression of which just one was successful.  
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The biochemical assays and the experiments on the photochemical reduction of FAD 
could not confirm complete substrate consumption. It is known that monooxygenases 
have a lower stability compared to other enzymes, which limits the turnover numbers of 
the biocatalysts using isolated enzymes[22-25].  
Another plausible reason could be the inefficient transfer of the reduced FAD from the 
flavin reductase to the monooxygenase. Gassner et al.[130] suggested that 
two-component monooxygenases would form a transient flavin transfer complex in 
which the AMP moiety is associated with the monooxygenase, and the isoalloxazine ring 
is redirected for binding in the catalytically active site of the flavin reductase. Based on 
this hypothesis, the release and transfer of the isoaloxazine ring would be more efficient 
and minimize the interaction with molecular oxygen from the solution (Figure 69). 
5.  
 
 
Figure 69 Proposed model for the 
transient flavin transfer complex (figure 
adopted from [130]) 
 
 
 
 
 
 
As was described in chapter 4.7 the affinity of ADP and AMP for the monooxygenase 
component PhzO could not be detected. In consequence and in contrast, the present 
results lead to the assumption that FADH2 transfer from the flavin reductase to the 
monooxygenase occurs randomly and is more likely to be dependent upon the 
concentration of the FAD in the solution or inner cell environment than upon the 
formation of any transient flavin-dependent complex. The concentration of FAD in living 
cells is uncertain and very much dependent on various physiological conditions. It was 
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reported that FAD could reach concentrations of about 0.2 mM in the living cell[132]. 
Whether the concentration of FAD is high enough in order to explain its low binding 
affinity to the enzyme PhzO remains unclear. 
The biochemical assays were performed with the flavin reductase from E.coli and not 
with the one belonging to each monooxygenase, from P. aureofaciens and C. necator 
respectively. This could be another reason why the experiments lacked the efficiency of 
flavin transfer resulting in incomplete substrate cunsoption. 
In case of PhzO, its substrate PCA is known to be biosynthesized in its reduced form but 
in the experiments performed in this work, mostly its oxidized form was used. TCP, the 
substrate of TcpA, has low water solubility. 3 chlorine atoms as substituents decrease 
the electron charge due to –I effect and hence the aromatic derivate is less succeptible 
to oxidation.  
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6. SUMMARY AND OUTLOOK 
Biotechnology is understood as the application of living organisms, enzyme complexes 
or single enzymes in production processes. Common classes of enzymes in the 
biotechnological processes are monooxygenases. These enzymes are used in 
biodegradation of xenobiotics e.g. TcpA from Cupriavidus necator, as well in generation 
of various compounds with antibiotic properties e.g. PhzO from Pseudomonas 
aureofaciens. Monooxygenases are able to transfer an atom of oxygen from molecular 
oxygen into the substrate. The reactions catalyzed by PhzO and TcpA respectively occur 
in tandem with a flavin reductase which provides monooxygenases with the cofactor 
FADH2. Such co-operativity of the enzymes makes the monooxygenases PhzO and TcpA 
belong to the protein superfamily of two-component flavin-diffusible monooxygenases 
(TC-FDM).  
The focus of work presented here is a structural and biochemical characterization of 
two two-component flavin-diffusible monooxygenases PhzO and TcpA. In order to 
describe the molecular structure and function of PhzO and TcpA, these two proteins 
were cloned, expressed, purified, crystallized and characterized using a variety of 
different biochemical and biophysical techniques. For detailed structural characterization 
of both enzymes, X-ray crystallography methods were used and novel biochemical 
assays were developed for investigating the substrate turnover in the catalyzed 
reactions via APCI-MS measurements. For an extensive functional characterization, 
isothermal titration calorimetry measurements were performed.  
6.1 PhzO 
The crystallization of PhzO was successful both in the native state and in complex with 
the ligands FAD, ADP and FMN. The native crystals were used for x-ray data set 
collection and showed diffraction of up to 1.7 Å. Analysis of the crystals with the ligands 
ADP and FMN resulted in no additional electron density in the active site. PhzO-ADP 
crystals obtained via co-crystallization were soaked in FAD and used for x-ray diffraction 
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analysis in order to determine the structure of the PhzO-FAD complex. A crystal 
structure at 3.2 Å was determined for this protein complex. The position of FAD 
indicates that the binding occurs mainly through the ADP-part and that isoalloxazine 
ring is not within the binding pocket. This result is in contradiction with ITC 
measurements.  
The ITC measurements showed that the complex of PhzO with FAD is characterzied by 
a dissociation constant of 13 µM and a reaction enthalpy of -4.7 kJ mol-1. Further ITC 
measurements have revealed that the isoalloxazine ring of FAD is most probably 
responsible for the complex formation. 
HPLC-APCI-MS measurements demonstrated that PhzO catalyzes the reaction in which 
the substrate PCA is converted to 2OHPCA. Despite much effort, complete substrate 
consumption could not be achieved since the reaction stopped after a short time. A 
quantitative interpretation of the substrate turnover was not possible. 
Docking and modeling experiments performed with PhzO and HpaB complexed with 
FAD showed that in PhzO the amino acids R109, T156 to R166, T202, E263 and R450 
to S461 are responsible for the binding of FAD. Based on the findings about the related 
structure of HpaB complexed with FAD, a model of the complex PhzO-FAD could be 
designed.   
6.2 TcpA 
The second enzyme described in this study was crystallized in the native form and as 
selenium-L-methionine derivative, although crystallization experiments were difficult to 
perform. Unfortunately, co-crystallization and soaking experiments failed, and it was not 
possible to study cofactor and ligand binding based on structural analysis. Docking and 
modeling experiments with the HpaB complexed with FAD and substrate found in 
scientific literature and with TcpA were performed in order to determine the amino acid 
residues which could be involved in protein-cofactor and protein-substrate interaction.  
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6.3 Outlook 
Experiments pertaining to reaction catalysis could not show complete substrate 
consumption. A plausible reason for that could be that PCA as substrate of PhzO is 
known to be biosynthesized in its reduced form but in the experiments performed in 
current work, mostly its oxidized form was used. For TcpA, its substrate TCP has low 
water solubility which makes it hard to work with and its 3 chlorine atoms lowers the 
electron charge of the phenol derivate making it hard to be oxidized. Another reason 
could be that biochemical assays were performed with the flavin reductase from E.coli 
and not with the one belonging to each monooxygenase, from P. aureofaciens and C. 
necator respectively. 
By determining the protein structures of PhzO and TcpA and comparing them with the 
HpaB model, it would be possible to determine which amino acids are involved in 
changing substrate specificity, making the enzymes more interesting for 
biotechnological applications. Based on these findings, one can generate mutants and 
express them either heterologously in E. coli for further biochemical assays or for in 
vivo cell studies in P. aureofaciens. In order to determine the substrate specificity, in 
vivo experiments could be performed, where the gene phzO is initially knocked out but 
reintroduced later as a plasmid DNA. It is assumed that monooxygenases treated in this 
work could accommodate a broad spectrum of substrates. Screening these enzymes 
against a class of compounds similar to the original substrates could reveal yet 
unknown, but possibly desirable functions.  
To monitor the reactions catalyzed by the monooxygenases described in this work, and 
also the concentration of O2 a clark electrode could be used. It is known that the 
solubility of O2 in aqueous solutions at atmospheric pressure and 20 ˚C is about 
7,6 mg l-1 [129]. This oxygen can be used either in the hydroxylation of the substrate or 
in the reduction to H2O2 by FADH2. In order to prevent H2O2 accumulation at the 
expense of dissolved oxygen, catalase can be added to the reaction mixture which 
should increase the efficiency of the substrate turnover. 
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6.4 Zusammenfassung 
Die Globalisierung und die drohende Erschöpfung der wichtigsten natürlichen Rohstoffe 
zwingen die Menschheit dazu, die Herstellungsprozesse einer wachsenden Anzahl von 
Produkten zu überdenken. Anhand von zahlreichen Beispielen aus der Natur gelingt es 
Biochemikern und Biotechnologen in zunehmendem Maße, moderne 
Herstellungsverfahren für die benötigten Produkte zu entwickeln. Dadurch ist das Feld 
der Biotechnologie entstanden, die als die Nutzung von lebenden Organismen, 
einzelnen Enzymen oder Enzymkomplexe in technischen Prozessen durch den Menschen 
definiert wird.  
Eine Klasse oft genutzter Enzyme in biotechnologischen Prozessen sind die 
Monooxygenasen. Diese Enzyme sind an biologischen Abbauprozessen von Xenobiotika 
und Schadstoffe beteiligt, wie z.B. TcpA aus Cupriavidus necator, sowie bei der 
Erzeugung verschiedener Verbindungen mit antibiotischen Eigenschaften wie z.B. PhzO 
aus Pseudomonas aureofaciens. PhzO und TcpA gehören zu der Proteinfamilie der „Two 
Component Flavine Diffusible Monooxygenases“ (TC-FDM).  
Das Ziel dieser Studie war es, die Struktur, den Reaktionsmechanismus und die 
Substratspezifität der Monooxygenasen PhzO und TcpA zu untersuchen. Zu diesem 
Zweck wurden beide Proteine kloniert, überexprimiert, aufgereinigt, kristallisiert und 
mittels verschiedener biochemischer und biophysikalischer Verfahren analysiert. Für 
eine detaillierte strukturelle Charakterisierung der beiden Enzyme wurde die Methode 
der Röntgenstrukturanalyse verwendet. Zur Untersuchung des Substratumsatzes in den 
katalysierten Reaktionen wurden APCI-MS-Messungen durchgeführt und die 
Bindungsaffinität der Enyzme an Substrat und Kofaktoren wurde über ITC-Messungen 
bestimmt. 
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6.4.1 PhzO 
Die Kristallisation von PhzO gelang sowohl im nativen Zustand wie im Komplex mit den 
Liganden FAD, ADP und FMN. Die nativen Kristalle hatten die Raumgruppe C2221 und 
zeigten eine Beugung von bis zu 1.7 Å. Das endgültige Modell von nativem PhzO wurde 
bis zu einer Auflösung von 1.7 Å mit R =18% und Rfree = 20% verfeinert. 
Die Analyse der Kristalle mit den Liganden ADP und FMN ergab keine zusätzliche 
Elektronendichte im aktiven Zentrum. PhzO-ADP-Kristalle wurden mittels Co-
Kristallisation gezüchtet und anschließend in eine FAD-Lösung eingetaucht, um die 
Struktur des PhzO-FAD-Komplexes zu bestimmen. Eine Kristallstruktur mit der 
Raumgruppe C2221 bei 3.2 Å und mit R = 15.8% und Rfree = 20% wurde für diesen 
Protein-Komplex bestimmt. Die Position des FAD weist darauf hin, dass die Bindung 
hauptsächlich durch den ADP-Teil erfolgt und dass der Isoalloxazinring nicht an dieser 
Bindung teilnimmt. Dieses Ergebnis steht im Widerspruch zu den ITC-Messungen. 
Die ITC-Messungen zeigten, dass der Komplex aus PhzO mit FAD durch eine 
Dissoziationskonstante von 13 µM und eine Reaktionsenthalpie von -4.7 kJ mol-1 
charakterisiert ist. Der Isoalloxazinring von FAD ist höchstwahrscheinlich für die 
Komplexbildung verantwortlich. 
HPLC-APCI-MS-Messungen haben gezeigt, dass PhzO die Reaktion katalysiert, in der 
das Substrat PCA zu 2OHPCA umgesetzt wird. Trotz vieler Versuche konnte ein 
vollständiger Verbrauch des Substrats nicht realisiert werden. Es wird angenommen, 
dass der Grund dafür die ineffiziente Übertragung des reduzierten Flavins (FADred) aus 
der Flavin-Reduktase-Komponente (Fre) auf die Monooxygenase (PhzO) ist. 
Docking- und Modellierungsexperimente mit PhzO- und HpaB-FAD-Proteinkomplex 
zeigten, dass in PhzO die Aminosäuren R109, T156 bis R166, T202, E263 und R450 bis 
S461 für die Bindung von FAD zuständig sind. Basierend auf den Kenntnissen über die 
Struktur von HpaB könnte die korrekte Bindung von FAD in das PhzO zu 
Konformationsänderungen führen, die das aktive Zentrum für das Substrat PCA 
zugänglich machen. 
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6.4.2 TcpA 
Das zweite in dieser Arbeit beschriebene Enzym wurde in der nativen Form und als 
Selen-L-Methionin-Derivat kristallisiert. Die Proteinstruktur des nativen TcpAs wurde bei 
3.0 Å aufgeklärt und bis auf R = 18% und Rfree = 25% verfeinert. Kokristallisation und 
soaking-Experimente mit Kofaktor und Substrat scheiterten, sodass eventuelle 
Komplexbildungen nicht über die Strukturanalyse untersucht werden konnten. Mit den 
in der wissenschaftlichen Literatur veröffentlichten Strukturen  für HpaB, HpaB-FAD und 
HpaB-FAD-Substrat und mit TcpA wurden Docking- und Modellierungsexperimente 
durchgeführt, um die Aminosäurereste zu bestimmen, die in TcpA-FAD und TcpA-TCP 
Komplex-Wechselwirkungen beteiligt sein könnten. So wurde gezeigt, dass die 
Aminosäuren P156, T192, Q451 an der TCPA-FAD Komplexbildung beteiligt sein 
könnten. 
 
6.5 Ausblick 
Um einen besseren Substratverbauch zu ermöglichen, könnte man die reduzierte Form 
von Phenazin-1-Carboxylsäure (PCA) als Substrat benutzen. Aus der Literatur ist es 
bekannt, dass Zellen PCA in seiner reduzierten und nicht in der oxidierten Form 
produzieren, welche in den Experimenten dieser Arbeit verwendet wurde. Im Falle von 
TcpA hat das dreifach chlorierte Phenol (TCP) eine geringe Wasserlöslichkeit, was die 
Experimente erschwert. Durch Zugabe von kleinen Mengen an organischen Solventen 
wie DMSO könnte die Löslichkeit von TCP erhöht werden. Der Aromat mit drei 
Chloratomen ist wahrscheinlich elektronenarm und dadurch schwerer zu oxidieren. 
Die biochemischen Experimente wurden mit der Flavin-Reduktase aus E.coli 
durchgeführt. Um eine bessere Flavin-Übertragung zu ermöglichen, könnte man die 
Experimente mit den Reduktasen, die jeweils zu der Monooxygenase aus P. 
aureofaciens und C. necator gehören, wiederholen.  
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Durch die Bestimmung der Proteinstrukturen von PhzO und TcpA und deren Vergleich 
mit dem HpaB-Modell wäre es möglich zu bestimmen, welche Aminosäuren an der 
Substratspezifität beteiligt sind, wodurch die Enzyme interessanter für die 
Biotechnologie werden. Aufgrund dieser Kenntnisse könnten Mutanten erzeugt werden 
und entweder heterolog in E. coli überexprimiert werden, um weitere biochemische 
Assays durchzuführen, oder in P. aureofaciens-Zellen eingeführt werden, um dort die 
2-Hydroxy-Phenazinesäure (2OHPCA) Biosynthese zu untersuchen. Es wird davon 
ausgegangen, dass die Monooxygenasen, die in dieser Arbeit behandelt wurden, ein 
breites Spektrum an Substraten umfassen könnten. Screening dieser Enzyme gegen 
eine Klasse von Substratanalogons könnte noch unbekannte aber begehrte Funktionen 
zeigen. 
Als eine weitere Methode zur Überwachung der Reaktion könnte man die O2 
Konzentration in der Reaktionslösung mittels einer Clark-Elektrode messen. Es ist 
bekannt, dass die Löslichkeit von O2 in wässrigen Lösungen bei normalen Bedingungen 
etwa 7,6 mg l-1 beträgt[129] . Dieser Sauerstoff kann entweder bei der Hydroxylierung 
des Substrats oder bei der Reduktion zu H2O2 durch FADH2 verwendet werden. Um eine 
H2O2-Ansammlung auf Kosten von gelöstem Sauerstoff zu verhindern, könnte man 
Katalase zu der Reaktionsmischung geben. Dadurch sollte die Effizienz des 
Substratumsatzes erhöht werden. 
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8. APPENDICES 
 
Sequence alignment of PhzO, TcpA and HpaB 
                     10        20        30        40        50        60 
                      |         |         |         |         |         | 
PhzOxx0      MLDFQNKRKYLKSAESFKASLRDNR-TVIYQGQVVEDVTTHFSTAGGISQVAEIYEEQFS 
TcpAxx1      ---------MIRTGKQYLESLNDGR-NVWVGNEKIDNVATHPKTRDYAQRHADFYDLHHR 
HpaBxx2      ---------MARTGAEYIEALKTRPPNLWYKGEKVEDPTTHPVFRGIVRTMAALYDLQHD 
                        ::. .:  :*.    .:   .: ::: :**    .     * :*: :.  
Prim.cons.   MLDFQNKRKM3RTG33Y3ESL3D3RPNVWY3GEKVEDVTTHP3TRG33333A33YDLQH3 
 
                     70        80        90       100       110       120 
                      |         |         |         |         |         | 
PhzOxx0      GEHDDILTYVRPDGYLASSAYMPPRNKEDLASRRRAIMYVSQKTWG-THCRNLDMIASFT 
TcpAxx1      PDLQDVMTFVDKDGERRTMQWFGHYDKEQLRRKRKYHETIMREMAGASFPRTPDVNNYVL 
HpaBxx2      PRYREVLTYEE-EGKRHGMSFLIPKTKEDLKRRGQAYKLWADQNLG-MMGRSPDYLNAVV 
                 :::*:   :*      ::    **:*  : :       :  *    *. *    .  
Prim.cons.   P333DVLTYV32DG3R33M3333P33KEDL3RRR3A333333333GA333R3PD33N3V3 
 
                    130       140       150       160       170       180 
                      |         |         |         |         |         | 
PhzOxx0      VGMMGYLPTFR-----KKCPEYAENITEYHDYAERNSLYLSETIVDPQGYRARTHGTDLN 
TcpAxx1      QTYIDDPSPWETQTIGAEGKVKAKNIVDFVNFAKKHDLNCAPQFVDPQMDRSNPDAQQRS 
HpaBxx2      MAYAASADYFG---------EFAENVRNYYRYLRDQDLATTHALTNPQVNRARPPSGQPD 
                      :            *:*: ::  : . :.*  :  :.:**  *:.. . : . 
Prim.cons.   33Y333333F3TQTIG2222E3AENI33Y33YA333DL333333VDPQ33RARP333Q33 
 
                    190       200       210       220       230       240 
                      |         |         |         |         |         | 
PhzOxx0      LPPPDRAVMRINKQNAEGIWISGVKGVGTAAPQSNEIFVGSLFPAAPEES--FWAYVPVD 
TcpAxx1      P------GLRVIEKNDKGIVVSGVKAIGTGVAFADWIHIGVFFRPGIPGDQIIFAATPVN 
HpaBxx2      PY----IPVGVVKQTEKGIVVRGARMTATFPLADEVLIFPSILLQAGSEKYALAFALPTS 
                     : : ::. :** : *.:  .*     : : .  ::  .   .  :    *.. 
Prim.cons.   P2PPDR233RV3KQN3KGIVVSGVK33GT3333333I33GS3F33A33E32233AA3PV3 
 
                    250       260       270       280       290       300 
                      |         |         |         |         |         | 
PhzOxx0      APGVKIFCREIVSQPHASAYDHPLISKGEEAEAMVVFDNVFIPRWRIMAANVPELAS-AG 
TcpAxx1      TPGVTIVCRESVVKED--PIEHPLASQGDELDGMTVFDNVFIPWSHVFHLGNPEHAK--L 
HpaBxx2      TPGLHFVCREALVGGDS-PFDHPLSSRVEEMDCLVIFDDVLVPWERVFILGNVELCNNAY 
             :**: :.*** :   .  . :*** *: :* : :.:**:*::*  :::  .  * ..    
Prim.cons.   TPGV3IVCRE3VV33D2SP3DHPL3S3GEE3D3MVVFDNVFIPW3RVF3LGNPELA3NA3 
 
                    310       320       330       340       350       360 
                      |         |         |         |         |         | 
PhzOxx0      FFSLWTSYSHWYTLVRLETKADLYAGLAKVIMEVLGLEGIAVVRQRVSEIVQLAEILKGM 
TcpAxx1      YPQRVFDWLHYHALIRQSVRAELMAGLAILITEHIGTNKIPAVQTRVAKLIGFHQAMLAH 
HpaBxx2      GATGALNHMAHQVVALKTAKTEAFLGVAALMAEGIGADVYGHVQEKIAEIIVYLEAMRAF 
                   .     .:    .:::   *:* :: * :* :    *: ::::::   : : .  
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Prim.cons.   333333333H333L3R333KAEL3AGLA3LI3E3IG333I33VQ3RVAEII333EAM3A3 
 
                    370       380       390       400       410       420 
                      |         |         |         |         |         | 
PhzOxx0      CIASIETAEMSDGDILLPGHNALAAGRVFAMEKLPRVLHLLRELCGQGLILRFNEKDLAA 
TcpAxx1      IVASEELGFHTPGGAYKPNILIYDFGRALYLENFSQMIYELVDLSGRSALIFASE-DQWN 
HpaBxx2      WTRAEEEAKENAYGLLVPDRGALDGARNLYPR-LYPRIREILEQIGASGLITLPS-EKDF 
                : * .  .  .   *.      .* :  . :   :  : :  * . ::   . :    
Prim.cons.   33ASEE3A3333GG3L3P333ALD3GR3LY3E2L333I3EL3EL3G3S3LI333EKD333 
 
                    430       440       450       460       470       480 
                      |         |         |         |         |         | 
PhzOxx0      DAAFGQKFSWFLDTQSVGAREKNLLMNLVWDVAASEHSTRALVFEEQHALSEPLLRDNLV 
TcpAxx1      DEALNGWFERMNNGPVGQPHDRVKIGRVIRDLFLTDWGNRLFVFENFNGTPLQAIRMLTM 
HpaBxx2      KGPLGPFLEKFLQGAALEAKERVALFRLAWDMTLSGFGARQELYERFFFG--DPVRMYQT 
             . .:.  :. : :     .:::  : .:  *:  :  . *  ::*.        :*     
Prim.cons.   D3ALG33FE3FL3G3333A3ERV3L3RL3WD33LS33G3R33VFE3F33322333RM333 
 
                    490       500       510       520       530 
                      |         |         |         |         | 
PhzOxx0      LDYDYRES----------------------------------TSLIRRLVGLNAK--- 
TcpAxx1      QRAEFSAAGPYGTLARKVCGIELTEGHDSEYKATAGYAQALDSARHQEKLALSGTMTV 
HpaBxx2      LYNVYNKE--------------------P-------YKERIHAFLKESLKVFEEVQA- 
                 :                                     :   .    :.        
Prim.cons.   L333Y333GPYGTLARKVCGIELTEGHD2EYKATAGY2222233L333L33L33322V   
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The Ramachandran diagrams for PhzO and TcpA 
PhzO TCPA  
In Preferred Regions: 614 (96.65%) In Preffered Regions: 431 (92.89%) 
In Allowed Regions: 9 (1.89%) In Allowed Regions: 23 (4.96%) 
Outliers: 7(1.47%) Outliers: 10 (2.16%) 
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